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The skin forms the body’s extremely efficient barrier, which prevents the loss of excessive water 
from the body and ingress of xenobiotics during exposure to the biologically hostile environment. 
Nevertheless, compounds frequently contacting with human skin can be dermally absorbed to the 
extents associated with their chemical structures (Flynn, 1990; Potts and Guy, 1992). Moreover, 
transdermal delivery provides an appealing alternative to other modes of administration in view 
of the advantages it owns, including sustained and controlled delivery, direct access to target site, 
the avoidance of first pass metabolism and improved patient acceptance and compliance and so 
on (Brown et al., 2006).  
       Skin permeability is a critical parameter for estimating the dermal absorption for compounds 
through the skin. Over the past decades, experimentally measured values of skin permeability for 
many compounds have been reported. However, measurements do not exist for more compounds 
with the potential for dermal absorption. Hence, various predictive models based on the different 
assumptions of the fundamental mechanisms underlying skin permeation have been proposed in 
order to estimate the unavailable permeability (Mitragotri et al., 2011). Among these models, the 
best known and most applied type is the quantitative structure-permeability relationship (QSPR) 
proposed by Potts and Guy (1992), generally written as follows: 
log Kp = a + b ∙ log P – c ∙ MV                     (1.1) 
where Kp is the skin permeability of the compound through the skin, commonly equated with the 
stratum corneum (SC) permeability as the dominant resistance to permeation of most compounds 
comes from the SC (Michaels et al., 1975); P describes the partition in model vehicles that mimic 




(MW); a, b and c are the constants. Such a QSPR equation was in reality deduced on the basis of 
Fick’s first law that describes steady-state diffusion through membrane:  
Kp = Ksc ∙ Dsc/hsc     (or   log Kp = log Ksc + log Dsc – log hsc)          (1.2) 
Here, Ksc, Dsc and hsc are the partition coefficient, the diffusion coefficient and the diffusion path 
length in the SC treated as a pseudo-homogenous membrane, respectively. Because both Ksc and 
Dsc are not easily determined, their values have to be estimated from some more readily available 
parameters in practice. In general, P in various model vehicles is used instead of Ksc, while Dsc is 
supposed to depend inversely upon molecular volume (Flynn, 1990; Potts and Guy, 1992). Thus, 
it is the case in Eq. 1.1. Octanol is by far a widely-used model solvent for the SC, partially due to 
the facts that the octanol-water partition coefficient (Poct) for chemicals can be easily found out in 
the literature, or calculated from molecular structure (Mannhold and van de Waterbeemd, 2001), 
and correlate well with the partition coefficient in lipid bilayers (Burns et al., 2002; Diamond and 
Katz, 1974). As a representative instance, Potts and Guy (1992) took advantage of experimental 
skin permeability data compiled by Flynn (1990) from aqueous solution on about 90 compounds 
to generate a renowned equation on the lines of Eq. 1.1: 
log Kp = – 6.3 + 0.71 log Poct – 0.0061MW  (R2 = 0.67)           (1.3) 
        However, such models were constructed upon Kp data sets for neutral species only. And in 
some cases, ionization of basic and acidic penetrating chemicals was selectively ignored. This is 
due to the fact that it is extremely difficult to set up an equation for skin permeation that includes 
both neutral species and ionic species. On the one hand, ionizable solutes exist both as separated 
ions (anions and cations) and as ion-pairs in octanol; the experimentally measured Poct values for 
separated ions are those for a neutral combination of anion and cation, and single-ion Poct values 




Acree, 2010d). On the other hand, Poct fails to encode some important recognition forces between 
ionic species and biological membranes (Avdeef et al., 1998). Consequently, the liposome-water 
partition has been developed as a promising model for the SC-water partition because of the lipid 
bilayer microstructure of liposome (Wang et al., 2009; Xian et al., 2008). However, this aspect of 
study is, up to now, too rough to answer the fundamental questions, e.g., whether or not liposome 
can model the SC in partition processes, and further whether or not Eq. 1.1 using liposome-water 
partition parameters provides a reasonable prediction for log Kp of ionic species. 
       One feasible method for predicting log Kp of ionic species is through the linear-free energy 
relationship (LFER) developed by Abraham and Acree (2010a, b, c, d). The LFER can be used to 
predict biological membrane permeability of both neutral and ionic species, and has been applied 
to blood-brain barrier (BBB) permeability (Abraham, 2011). It is also the key analytical method 
of this study. This LFER full of intelligence will be introduced in great detail below. 
1.1 Structure of Skin 
The skin covers the entire outer surface of the body. Structurally, the skin consists of two distinct 
layers: the epidermis and the dermis. The epidermis is the outer layer, serving as the physical and 
chemical barrier between the interior body and the exterior environment; the dermis is the deeper 
layer, providing mechanical support and protection to the underlying muscle, bones and organs, 
as well as the structural support of the skin. Beneath the dermis lies hypodermis or subcutaneous 
fatty tissue, which binds the skin to the underlying structures and stores energy in the form of fat. 
Hair, nails, sebaceous glands, eccrine and apocrine sweat glands are known as the appendages of 
the skin. These appendages can be found to disperse throughout the skin, varying in number and 






Figure 1.1 A cross-sectional diagram of the skin, source: http://body-disease.com/page/19/ 
1.1.1 Epidermis (and Stratum Corneum) 
The epidermis is a thin, stratified squamous epithelium mainly composed of keratinocytes, which 
synthesize the protein keratin. The epidermis is in a constant state of transition, as the inner cells 
moving upward to the surface continuously replace the outer cells until being shed, accompanied 
by their differentiation (or keratinization). The differentiation process is essentially characterized 
by an accumulation of three types of species, i.e., cytokeratins, other proteins in the keratohyalin 
granules and lipids, and a degradation of all of the internal organelles. The five distinct layers of 
the epidermis are formed by the differing stages of differentiation, from bottom to top, including 
the basal layer (stratum basale), the spinous layer (stratum spinosum), the granular layer (stratum 
granulosum), the clear layer (stratum lucidum) and the horny layer (stratum corneum). The cells 
become wider and flatter as they move from the stratum basale towards the surface (see Fig. 1.2). 
Over most of the body, the epidermis is on the order of 100 μm thick. The complete renewal of 




                
                                       (a)                                                                          (b) 
Figure 1.2 Cross-section of the epidermis:  
(a)  A artificial sketch, modified from source: http://totalskinmanagement.com/skin-structure/ 
(b) A micrographic picture for thick epidermis using trichrome, from the kind share of Lutz Slomianka: 
http://www.lab.anhb.uwa.edu.au/mb140/. Note that the stratum lucidum is a transitional and translucent 
layer between the stratum granulosum and the stratum corneum, and is not usually seen in thin epidermis. 
       The stratum corneum is the final outcome of the differentiation process, which is made up of 
layers of extremely flattened, hexagonal-shaped, cornified and dead cells known as corneocytes. 
The corneocytes are stacked 15-25 layers deep in most areas of the skin, each of which is about 
30 μm in diameter and 0.5-0.8 μm in thickness (Holbrook and Odland, 1974). Each corneocyte is 
filled with densely packed keratin proteins, bounded by a protein envelope and embedded into an 
intercellular lipid matrix. Virtually all of the lipids in the stratum corneum are in the intercellular 
space, being present in stacked lipid bilayers, except for a small part in residual cell membranes. 
This compact and continuous structure provides the primary permeability barrier of the skin. The 
lipid content takes up 10-20% of the stratum corneum’s dry weight, while the proteins contribute 




lipids: ceramides, cholesterol, and saturated fatty acids. These lipids account for about 50%, 25%, 
10% of the lipid mass, respectively (Law et al., 1995). Cholesterol esters, cholesterol sulfate, and 
glucosylceramides are present in minor amounts (Michniak-Koln et al., 2005). 
       Moreover, in health skin at ordinary relative humidity, the water content of stratum corneum 
is normally roughly 15-20% (Lu and Flynn, 2009). The water-retaining keratin certainly plays an 
important role in consequence here. Should the skin become fully hydrated, the stratum corneum 
can absorb up to three times its dry weight of water.  
1.1.2 Dermis 
The dermis lies below and immediately connects with the epidermis, often referred to as the true 
skin. As the major portion of the skin, it varies in thickness from 0.6 mm on the eyelids to 3 mm 
on the back, palms and soles. Its structure is held together by a tough meshwork of structural fi-
bers, e.g., collagen, elastin, and reticulin. The space between these fibers is mostly filled with a 
mucopolysaccharidic gel called the ground substance. Collagen represents approximately 75% of 
the dermis composition, providing strength and toughness (Lu and Flynn, 2009).  
       The dermis may be divided into two sublayers without a shape boundary: the papillary layer 
and the reticular layer. The papillary layer is the thin upper layer in contact with the deep surface 
of the epidermis, consisting of loose, relatively cell-rich connective tissue. Note that the interface 
between the epidermis and the dermis is not flat but papillose. The papillary layer bulges into the 
epidermis, which houses the capillary plexus that nurture the epidermis. The thick reticular layer 
is the lower layer, which appears denser and contains fewer cells. In the papillary layer, collagen 
fibers are finer and more arranged, while coarser collagen fibers often aggregate into bundles and 
form an interlacing network in the reticular layer. The dermis basically comprises fibroblasts that 
synthesize the structural fibers, mast cells that are considered to synthesize the ground substance, 




skin is entirely located in the dermis. Also, embedded in the dermis are the dermal sensory nerve 
endings and a widespread lymphatic network. In addition, sweat glands, hair follicles associated 
with sebaceous glands, and small amounts of striated muscle are anchored within the dermis. 
1.2 Transdermal Permeation Pathways 
As is well known, the stratum corneum serves as the predominant permeability barrier of the skin 
(Blank and Scheuplein, 1969; Scheuplein, 1965; Scheuplein and Blank, 1971, 1973). In general, 
the stratum corneum barrier is simplified as an idealized “bricks-and-mortar” model (Elias, 1983; 
Michaels et al., 1975). This model is composed of an array of corneocytes (bricks) with the space 
between them filled with lamellar lipids (mortar), as illustrated in Fig. 1.3. It has constituted the 
base for understanding the nature of the permeation of chemicals through intact stratum corneum 
to date. The model indicates that one substance permeates across the barrier, either by movement 
alternately through the intercellualr lpid matrices and corneocytes (i.e., transcellular route), or by 
movement continuously though the intercelluar lipid matrices (i.e., intercellular route). However, 
a substantial amount of evidence points to the fact that the intercellular pathway is, in reality, the 
major permeation route for most compounds, both lipophilic and hydrophilic. These observations 
includes increased permeabilities after extraction or alteration of the SC lipids (Mitragotri et al., 
1996; Scheuplein, 1967; Scheuplein and Blank, 1971), high lipids-water partition coefficents and 
low corneocyte-water partition cofficents (Raykar et al., 1988), and correlation between transport 
enhancement by cheimials and ultrasound and their action site, i.e., the lipid phase (Mitragotri et 
al., 1995; Potts and Francoeur, 1990). More directly, Bodde et al. (1991) and Nemanic and Elias 
(1980) visualized the permaetion pathways of an inorganic ion Hg2+ and n-butanol, respectively, 
using vapor fixation and electron microscopy, and confirmed that both substances preferentially 
traverse the stratum cornuem between corneocytes rather than through them. Moreover, Lu and 




to organic molecules that may become dissolved within it. Moreover, because of its remarkable 
ionic character, the intracellular keratin mass borders on being thermodynamically impenetrable.”  
                      
Figure 1.3 Schematic diagram of the bricks-and-mortar model of the stratum corneum with possible drug 
penetration pathways through intact stratum corneum. Also shown is a lamellar model of intercellular 
domain showing the main stratum corneum lipids; modified from Williams and Barry (1992). 
       Although the intercellular pathway is the principal permeation route of the stratum corneum, 
it is known that the permeability coefficients of excessively hydrophilic compounds could not be 
explained by the intercellular lipid-based pathway only (Ackermann and Flynn, 1987; Peck et al., 
1994). Hence, workers believe that transdermal transport of very hydrophilic compounds mainly 
takes place via an “aqueous pore” pathway instead of the lipid pathway (Ackermann and Flynn, 
1987; Menon and Elias, 1997; Peck et al., 1994; Williams and Elias, 1987). And, these “aqueous 
pores” are thought to be created by the defects in the intercellular lipid bilayers, including multi-
molecular nucleated defects, molecular packing defects, missing lipids and transient fluctuation 
(Mitragotri, 2003; Sznitowska et al., 1998). Very hydrophilic compounds can be characterized by 




       In addition to “aqueous pores”, the appendages (i.e., hair follicles and sweat ducts) also offer 
a transdermal transport pathway for hydrophilic compounds. But due to the extremely small area 
fraction (about 0.1%) of the skin covered by the appendages transport through them is generally 
neglected. Upon mathematical modeling, Mitragotri (2003) proposed that the contribution of the 
appendages is dominant for large hydrophilic compounds (MW > 100,000 Da) only.  
       In brief, the intercellular lipid bilayers function as the non-polar pathway for transport across 
the barrier, while “aqueous pores” present in the lipid bilayers and the appendages constitute the 
polar pathway. Both pathways exist simultaneously, but their respective contributions to the total 
permeation depend on the physiochemical properties of the permeant, especially the lipophilicity. 
1.3 Measurement of Lipid Membrane-Water Partition 
Liposomes have been used as model membranes to study the interaction between solutes and 
biological membranes since their first introduction by Bangham and his coworkers (Bangham et 
al., 1965a; Bangham et al., 1965b). This is obviously because liposomes significantly reproduce 
the lipidic assembly mode (i.e., anisotropic highly-ordered bilayers) in biological membranes, in 
which the lipid domain is the principal pathway for passive diffusion of drugs and physiological 
matters. The partitioning behavior of solutes between liposomal membranes and aqueous phases 
can provide a reasonable estimate for their in vivo affinity to biological membranes.  
        However, the application of liposome-water partitions has ever been severely restricted by 
the conventional techniques (collectively called shake-equilibrium method) to characterize them, 
which differ from each other in terms of the means for separating liposomal and aqueous phases 
after partition equilibrium (e.g., dialysis, ultrafiltration, centrifugation), because these techniques 
are labor-intensive and time-consuming and therefore are of little use in routine work. In recent 
years, high-throughput chromatographic techniques have been developed for rapid and efficient 




membrane (IAM) chromatography, immobilized liposome chromatography (ILC) and liposome 
electrokinetic chromatography (LEKC). They exhibit many attractive advantages, such as speed, 
small sample amount, automation, low sample purity requirement and high reproducibility. The 
current techniques used to characterize lipid membrane-water partitions and their advantages and 
disadvantages are summarized in Table 1.1. Here, the chromatographic techniques will be intro-
duced in detail. 
Table 1.1 Current techniques for analyzing the lipid membrane-water partitions and their characters. 
Techniques Advantages Disadvantages Others 








Relatively higher speed; 
log Plip values for both ionic 
and neutral speciesa 








small sample amount; 
low purity requirement 
Lipid monolayer with lack of 
lateral mobility of lipids and 
density of phospholipid 
head-groups  






small sample amount; 
low purity requirement 
Unstable; irreproducible 
column preparation; unsuita-
ble for lipophilic solutes 
(long retention times for 
many neutral molecules) 




small sample amount; 
low purity requirement 
Unsuitable for neutral so-
lutes with neutral liposomes 
used 
Set up on capillary electro-
phoresis (CE) 
a log Plip represents the partition coefficient between liposome and water. 
1.3.1 Immobilized Artificial Membrane (IAM) Chromatography   
Immobilized artificial membrane (IAM) chromatography is a chromatographic technique set up 
on high-performance liquid chromatography (HPLC). Originally developed by Pidgeon and his 




phase consists of a monolayer of phospholipids covalently immobilized on an inert silica support. 
The resulting IAM surface is a chemically stable chromatographic material in both aqueous and 
organic solvents, which mimics the lipid environment of a fluid cell membrane on a solid matrix. 
Fig. 1.4 illustrates the structures of Pidgeon’s IAM stationary phases (Ong and Pidgeon, 1995). 
IAM chromatography is quite useful for the analytical and preparative separation of membrane-
associated proteins (Pidgeon et al., 1991), and has recently gained acceptance for monitoring the 
interaction of solutes with biological membranes (Taillardat-Bertschinger et al., 2003).  
         IAM chromatography measures the “phospholipophilicity” of solutes, including neutral and 
ionic species, where the lipophilicity index is the capacity factor (as log kIAMw) at 100% aqueous 
solution being mobile phase. For hydrophilic compounds, log kIAMw can be measured directly by 
using aqueous mobile phase. But for lipophilic compounds, log kIAMw values have to be deduced 
by extrapolating a linear curve made from the capacity factors (log k) at different concentrations 
of an organic modifier (e.g., methanol) to pure aqueous mobile phase, due to their long retention 
times at aqueous mobile phase. The relationship between log kIAMw and log k is described by Eq. 
1.4, where φ is the volume fraction of organic solvent and S is the constant for a specific organic 
modifier. When φ is zero, that is, the mobile phase is pure aqueous solution, log k is equal to log 
kIAMw. Here, log k was calculated in accordance with the common definition of “capacity factor” 
in chromatography. 
  log k = − S∙φ + log kIAMw        (1.4) 
         Certainly, nothing is perfect. Covalent immobilization of phospholipid ligands brings forth 
the chemical stability of IAM surface, but it also reduces lipids’ lateral mobility. Further, Ong et 
al. (1996) reported that the density of the polar phospholipid head groups in IAM is less than that 
in liposomes. It is also known that the polar head-groups are an important factor for substances 




present in the form of lipid monolayers. A more adequate phase for modeling the environment of 
biological membranes is perhaps provided by lipid bilayers, composed of mobile lipid molecules 
forming a hydrophobic region sandwiched between two interfacial hydrophilic layers.  
 
Figure 1.4 Structures of Pidgeon’s immobilized artificial membrane (IAM) stationary phases; modified 
from Ong and Pidgeon (1995)and Kaliszan (1999). 
1.3.2 Immobilized Liposome Chromatography (ILC) 
Immobilized liposome chromatography (ILC) is also a HPLC-based technique, where liposomes 
are directly immobilized into gel beads as a stationary phase. Similarly to IAM chromatography, 
ILC can also be used for the study of biological membrane-solute interactions (Beigi et al., 1995; 
Lundahl and Beigi, 1997). This approach has been extended to comprise immobilized biological 
membrane vesicles (e.g., human red cell membrane vesicles) for quantitative binding analyses of 
substrates and inhibitors interacting with transport proteins (Brekkan et al., 1996; Lundqvist et al., 




      How to immobilize liposomes in gel beads is always a subject of focus for ILC, on which the 
stability of immobilized liposome stationary phases as well as the density of phospholipids in the 
gel does depend (Wiedmer et al., 2004). Several methods for liposome immobilization have been 
reported, including: (a) hydrophobic ligands (e.g., alkylsulfide) able to interact with hydrophobic 
parts of phospholipids were coupled to the matrix of gel beads (Khaleque et al., 2000; Sandberg 
et al., 1987); (b) large liposomes were sterically entrapped in the gel-bead pores, either by direct 
formation inside the beads upon dialysis of mixed detergent-lipid micelles (Wallsten et al., 1989), 
or by freeze-thawing of small liposomes introduced into the gel that resulted in their fusion and 
growth (Yang and Lundahl, 1994); (c) liposomes can also be covalently bound to gel matrix with 
the help of appropriate gel ligands (Yang et al., 1999); (d) liposomes containing biotin-attached 
phospholipids were immobilized in avidin- or streptavidin-derivatized gels by the strong avidin-
biotin binding (Yang et al., 1998). Among these techniques, the avidin-biotin technique produces 
the most stable stationary phases, partly because of the narrow size distribution of liposomes that 
was obtained, and the resultant homogeneous liposome-immobilized gels (Wiedmer et al., 2004). 
The tendency for phospholipid densities in the gel obtained by different immobilization methods: 
hydrophobic interactions ≈ freeze-thawing (steric) > avidin-biotin bonding > covalent bonding > 
dialysis (steric) (Wiedmer et al., 2004).   
        The lipophilicity index from ILC is expressed as the capacity factor (as log Ks) measured by 
HPLC using aqueous buffer eluent, which is calculated according to Eq. 1.5: 
Ks = (VR−V0)/A            (1.5) 
where VR and V0 are the retention volumes of the analyte and an unretained compound (usually 
being small and hydrophilic), and A is the amount of immobilized phospholipids.  
        Although ILC overcomes the disadvantages of IAM chromatography, where the fluidic lipid 




the difficulty of the long-term storage of liposome-immobilized stationary phases as well as the 
leakage of phospholipids during chromatographic runs. In addition, the preparation of the phases 
is short of reproducibility. More importantly, the use of organic modifiers in the mobile phases is 
avoided in ILC, which can destroy the phospholipid membrane, so that the retention of lipophilic 
compounds in the stationary phases is prolonged in normal measurements of log Ks. 
1.3.3 Liposome Electrokinetic Chromatography (LEKC) 
Unlike IAM chromatography and ILC, liposome electrokinetic chromatography (LEKC) utilizes 
the capillary electrophoresis (CE) instrument, but in this case liposomes are present in the buffer 
solutions. The liposomes function as a pseudo-stationary phase and provide partitioning sites for 
solutes. Fig. 1.5 illustrates the mechanism of migration and separation of two uncharged solutes, 
S1 and S2 in LEKC where the liposomes are negatively charged. The electrophoretic migration of 
the liposomes is toward the anode, but the stronger electroosmotic flow drives the liposomes and 
the solutes toward the cathode where they are detected. Uncharged solutes are separated accord-
ing to differences in liposome-water partitions (Burns and Khaledi, 2002).         
 
Figure 1.5 Schematic presentation of the migration pattern in LEKC with a negatively charged liposome. 
S1 and S2 represent two uncharged solutes partitioning into the liposome. μLip and μEOF are the mobilities 
of the liposome and the electroosmotic flow at a high voltage, respectively. As a result, teo, tr1, tr2, and tlip 
are the retention times of an unretained marker (e.g., methanol), two solutes, and a liposome marker (e.g., 




       A substantial number of publications on predicting analyte-membrane interactions by LEKC 
have been seen since the first use of LEKC on the separation of compounds (Zhang et al., 1995), 
as reviewed by Wiedmer and Shimmo (2009). The retention factor (as log k) is the lipophilicity 
index derived in LEKC. Two different procedures were performed in LEKC system to determine 
log k of charged solutes and neutral solutes respectively, since charged solutes possess their own 
electrophoretic mobility under voltage as compared to neutral solutes, as described in Eq. 1.6 for 
neutral solutes and in Eq. 1.7 for charged solutes.  
    k = (tr – t0)/ t0 (1 – tr/tlip)               (1.6) 
    k = (tr – teo)/ teo (1 – tr/tlip)             (1.7) 
In the equations, tr, teo and tlip are the retention times of the solute, the electroosmotic flow marker  
(e.g., methanol) and the liposome marker (e.g., decanophenone) in LEKC system, respectively; t0 
is the retention time of charged solutes in pure buffer solution. teo and t0 represent the unretained 
times of neutral solutes and charged solutes, respectively.  
        LEKC is a powerful tool for the study of drug-membrane interactions, which provides some 
particular advantages over those HPLC-based techniques. For example, the preparation of HPLC 
columns is generally tedious, time-consuming and costly so that adjusting the composition of the 
stationary phases to simulate specific biological membranes is not a trivial task. On the contrary, 
any type of liposomes can be used in LEKC whenever it is needed. Moreover, there is no storage 
problem for the liposomes in LEKC, since they may be easily and reproducibly prepared prior to 
use. Nevertheless, LEKC has an obvious disadvantage that when the net charge of the liposomes 
is neutral, uncharged solutes are impossibly distinguished. 




A LFER equation proposed by Abraham (1993) has been widely used to characterize a number 
of equilibrium systems, including in vivo and in vitro partition processes and transport processes, 
and to predict the corresponding equilibrium coefficients (Acree et al., 2012), including partition 
coefficients (e.g., log Poct and liposome-water partition coefficient, log Plip) and rate coefficients 
(e.g., log Kp and blood brain barrier permeability, log PBBB), see Eq. 1.8: 
     SP = c + eE + sS + aA + bB + vV                     (1.8) 
      Here and elsewhere, SP represents an equilibrium coefficient for a series of solutes in a given 
system. The independent variables are physicochemical properties or descriptors of the solutes as 
follows: E is the excess molar refraction in (cm3mol-1)/10, S is the solute dipolarity/polarizability, 
A and B are the overall hydrogen bond acidity and basicity, respectively, and V is the McGowan 
characteristic molecular volume in (cm3mol-1)/100. Eq. 1.8 was set up for processes that involve 
neutral species only. Abraham and Acree (2010a, b, c, d) found that it was necessary to introduce 
a new descriptor for cations, J+, and a new descriptor for anions, J-, in order to extend Eq. 1.8 to 
include ions and ionic species, leading to Eq. 1.9: 
SP = c + eE + sS + aA + bB + vV + j+J+ + j−J−           (1.9) 
        Note that J+ is zero for anions, J- is zero for cations, and both are zero for neutral species, in 
which case Eq. 1.9 reverts to Eq. 1.8. All the solute descriptors can be calculated or estimated as 
detailed previously (Abraham, 2011; Abraham and Acree, 2010a, b, c). The descriptors for ions 
and ionic species are on the same scales as those for neutral species, so that Eq. 1.9 can include 
ions, ionic species and neutral species. In this study, the term “ions” refers to permeant ions such 
as Na+ and Cl-, and the term “ionic species” refers to ions derived from protonation of bases and 
deprotonation of acids. Some examples of the descriptors used in Eq. 1.2 are shown in Table 1.2. 




(MLR). They are not only fitting coefficients, but serve to characterize the given system. So far, 
Eq. 1.9 has been proved to be a pretty good model that incorporates neutral and ionic species for 
the partitions between organic solvents and water (Abraham and Acree, 2010d), the diffusions in 
water and ethanol (Hills et al., 2011) and the permeation through BBB (Abraham, 2011). 
Table 1.2 Descriptors for some neutral species, ions and ionic speciesa 
Species E S A B V J+ J- 
Na+ −0.020 2.31 1.22 0.00 0.0330 0.316 0.000 
K+ 0.000 2.57 1.21 0.00 0.0920 0.357 0.000 
NH4+ −0.011 1.77 1.80 0.00 0.3399 0.370 0.000 
MeNH3+ 0.100 2.90 1.35 0.00 0.3708 0.722 0.000 
Me2NH2+ 0.039 2.41 1.00 0.00 0.5117 0.877 0.000 
Me4N+ −0.100 1.31 0.68 0.00 0.7635 1.255 0.000 
Cl‒ 0.100 3.52 0.00 2.32 0.2280 0.000 2.363 
I‒ 0.380 3.55 0.00 1.34 0.4080 0.000 1.251 
Acetate‒ 0.415 2.20 0.00 2.93 0.4433 0.000 2.075 
Benzoate‒ 0.880 3.64 0.00 2.88 0.9102 0.000 2.395 
Phenoxide‒ 0.955 2.80 0.00 2.12 0.7536 0.000 1.676 
Propanone 0.179 0.70 0.04 0.49 0.5470 0.000 0.000 
DMSO 0.522 1.72 0.00 0.97 0.6126 0.000 0.000 
Ethanol 0.246 0.42 0.37 0.48 0.4491 0.000 0.000 
Acetic acid 0.265 0.64 0.62 0.44 0.4648 0.000 0.000 
a the data taken from Abraham (2011). 
1.5 Aims of this Study 
The motivation for this study originated from an ambitious thought to construct a mathematical 
model for predicting skin permeability of both neutral and ionic species on the basis of simplicity, 
mechanistic relevance and predictive ability. As was introduced, there are two potential solutions: 
one is the Potts-Guy model, Eq. 1.1, based on liposome-water partition parameters, and the other 
is the LFER model, Eq. 1.9, from Abraham and Acree. In line with the above, the major aims of 




1)     To compare liposome-water partitions and organic solvent-water partitions with the SC-
water partition using LFERs in physicochemical nature. 
For this purpose, I measured the retention factors for a diversity of compounds (including neutral 
and ionized) in LEKC, where cerasomes consisting mainly of SC lipids and regular phospholipid 
liposomes consisting of 3-sn-phosphatidylcholine (POPC) and 3-sn-Phosphatidyl-L-serine (PS) 
(80:20, mol/mol) were employed as the investigated liposomes, respectively. Cerasome was used 
specifically to simulate the SC in the present study, given that the lipid composition of liposomes 
had a remarkable effect on their chemical similarity with the SC in terms of their phase behaviors 
and lateral diffusion coefficients (Johnson et al., 1997; Kitson et al., 1994; Ongpipattanakul et al., 
1994).  
2)     To investigate the feasibility of Eq. 1.1 that employs partition into liposomes as a model 
for the partition into SC to predict log Kp of both neutral and ionic species. 
To this end, the retention factors of solutes measured in liposome electrokinetic chromatography 
using cerasomes (also called cerasome EKC) were considered as an estimate of log Ksc in Eq. 1.1. 
The explanatory power of such a model for skin permeation was investigated for both species in 
this study. 
3)     To construct a LFER model for skin permeation of both species.  
Previously, Eq. 1.8 was applied to observed log Kp of 119 neutral solutes (Abraham and Martins, 
2004), leading to Eq. 1.9, with Kp in units of cm s
-1:  
 log Kp = −5.426 – 0.106E – 0.473S – 0.473A – 3.000B + 2.296V  (R2 = 0.832)    (1.10) 
Now that descriptors can be calculated or estimated for ionic species, Eq. 1.10 can be extended 




ionic species as well as neutral species, from known solute descriptors. To achieve this purpose, I 
have measured the log Kp values for 18 ionized solutes across human epidermis in this study, and 





2. Publication Overview 
2.1 Research Article 
Linear Free Energy Relationship (LFER) Analysis of Retention Factors in Cerasome  
Electrokinetic Chromatography (EKC) Intended for Predicting Drug Skin Permeation 
Keda Zhang, Ming Chen, Gerhard K. E. Scriba, Michael H. Abraham, Alfred Fahr, Xiangli Liu 
Journal of Pharmaceutical Sciences, 2012, 101(6): 2034-2044. 
Abstract: The retention factors for a great variety of compounds (including neutral and charged 
solutes) were measured in cerasome EKC system. The LFER model gave an account of these 
retention factors for both neutral and ionic species (R2 = 0.814, SD = 0.29 log units). The equa-
tion was compared with those for a number of solvent-water partitions. It was shown that cera-
some is quite different from organic solvents on interaction with solutes and hence that it could 
be a very useful model for the SC in partitions. 
 
Own contribution to the manuscript: 
1) Measurements of the retention factors for all the compounds in cerasome EKC. 
2) Data evaluation, interpretation and presentation of the results. 






2.2 Research Article 
Human Skin Permeation of Neutral Species and Ionic Species: Extended  
Linear Free-Energy Relationship Analyses 
Keda Zhang, Ming Chen, Gerhard K. E. Scriba, Michael H. Abraham, Alfred Fahr, Xiangli Liu 
Journal of Pharmaceutical Sciences, 2012, 101(6): 2034-2044 
Abstract: The permeabilities log Kp of nine acids and nine bases through human epidermis were 
measured in this work. Combing these data with the experimental log Kp data for neutral species 
from the Abraham-Martins database and reliable data for ionic species in literature, a LFER 
equation for skin permeation was deduced, with R2 = 0.861 and SD = 0.462 log units. This equa-
tion can be used to predict log Kp for both species, as well as partly ionized solutes. In addition, 
skin-water partition was compared with cerasome/organic solvent-water partitions using LFERs. 
The results show that partition into cerasome is a useful model for partition into skin. 
 
Own contribution to the manuscript:  
1) Measurements of skin permeability for all 18 compounds. 
2) Data evaluation, interpretation and presentation of the results. 





2.3 Research Article 
Comparison of Lipid Membrane-Water Partitions with Various Organic Solvent-Water 
Partitions of Neutral Species and Ionic Species 
Keda Zhang, Kewei Yang, Gerhard K. E. Scriba, Michael H. Abraham, Alfred Fahr, Xiangli Liu 
Journal of Pharmaceutical Sciences, being revised. 
Abstract: The retention factors for a reasonable number of neutral and charged solutes were de-
termined in LEKC, where liposomes (POPC80/PS20) were used. The LFER analysis was applied 
to these retention factors as well as the capacity factors in a reported neutral IAM system, which 
is used as a surrogate for neutral liposome-water partition. Some lipid membrane-water partitions 
whose ionic LFER equations are available, including the above two systems, were compared to a 
number of organic solvent-water partitions using LFERs. The results show that lipid membranes 
exhibit a fairly different chemical environment from those of organic solvents. Further, partitions 
into cerasome and phospholipid liposomes were compared to skin permeation. It was found that 
the cerasome-water partition exhibits a better chemical correlation to skin permeation.   
 
Own contribution to the manuscript: 
1) Measurements of the retention factors for all the compounds in LEKC. 
2) Data evaluation, interpretation and presentation of the results. 










Linear Free-Energy Relationship (LFER) Analysis of Retention Factors in 
Cerasome Electrokinetic Chromatography (EKC) Intended for Predicting 
Drug Skin Permeation 
Keda Zhang, Ming Chen, Gerhard K. E. Scriba, Michael H. Abraham, Alfred Fahr, Xiangli Liu 
Journal of Pharmaceutical Sciences, 2012, 101(6): 2034-2044 




Linear Free Energy Relationship Analysis of Retention Factors
in Cerasome Electrokinetic Chromatography Intended for
Predicting Drug Skin Permeation
KEDA ZHANG,1 MING CHEN,1 GERHARD K. E. SCRIBA,2 MICHAEL H. ABRAHAM,3 ALFRED FAHR,1 XIANGLI LIU1
1Department of Pharmaceutical Technology, Friedrich-Schiller-Universität Jena, 07743 Jena, Germany
2Department of Pharmaceutical Chemistry, Friedrich-Schiller-Universität Jena, 07743 Jena, Germany
3Department of Chemistry, University College London, London WC1H 0AJ, UK
Received 12 January 2011; revised 27 February 2011; accepted 1 March 2011
Published online 31 March 2011 in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/jps.22549
ABSTRACT: The retention factors of neutral, positively charged, and negatively charged
solutes were determined in a liposome electrokinetic chromatography (EKC) system, where
cerasome was used as the investigated liposome. The Abraham linear free energy relationship
(LFER) for neutral and ionized solutes gave a good account of the retention factors (N = 71,
R2 = 0.814, and SD = 0.29 log units). It was shown that the calculated retention factors for
16 neutral acids were about four times higher than those of the corresponding anions, whereas
the calculated retention factors for neutral bases were less than those for the corresponding
cations by a factor of 0.36. The LFER equation for neutral species, anions, and cations was
compared with those for partition from water into a number of solvents and for n-octanol–water
distribution coefficients. It was shown that the cerasome EKC system is substantially different
to the other systems and consequently it could be a very useful additional model system, possibly
for predicting skin permeation. It was further shown that there are considerable advantages in
the use of Abraham LFERs that can encompass not only neutral molecules but also ionic species.
© 2011 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 100:3105–3113,
2011
Keywords: liposome electrokinetic chromatography (LEKC); cerasome; retention factors;
log P; skin; liposomes; physicochemical properties; linear free energy relationship; QSPR;
ionic species
INTRODUCTION
Skin permeability is a critical parameter for trans-
dermal delivery of drugs and the risk assessment of
chemicals in contact with the skin, both in the phar-
maceutical and the cosmetic fields. Because of the
fact that measurement of the penetration of chem-
icals through skin either in vivo or in vitro is time
consuming and laborious, and may also give rise to
ethical difficulties,1 the prediction of skin permeabil-
ity using various model systems is an area of great
significance and of increasing interest.
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As Flynn proposed a working model of the skin to
assess the permeation of chemicals based on their
physicochemical properties,1,2 a great deal of work
has been conducted on experimental and theoret-
ical models to predict skin permeation. The most
recent developments have used immobilized artifi-
cial membrane3–6 (IAM) and micellar electrokinetic
chromatography7,8 (MEKC). Both systems involve
ordered lipid aggregates that are similar to biomem-
branes and, hence, could be useful models for perme-
ation through the stratum corneum. Subsequently, li-
posome electrokinetic chromatography (LEKC) was
developed as a logical consequence after the intro-
duction of micelles in electrokinetic chromatography
(EKC). Compared with IAM and MEKC, LEKC pro-
vides not only the measurement advantages, such
as speed, small sample amount, automation, lack of
sample purity requirement, and high reproducibility,
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but also a distinct lipophilicity index in pharmacoki-
netic studies, as liposomes possess spherical lipid bi-
layer microstructures that make them more suitable
models for the dynamic and fluid bilayer environment
of biomembranes. LEKC has been used to evaluate
the penetration of chemicals through skin in recent
years and the derived quantitative structure–perme-
ability relationship models showed adequate predic-
tive ability for skin permeation, as log Kp.9,10
However, LEKC research on skin permeation
has mostly been performed using the conven-
tional phospholipid system, phosphatidylcholine
(PC)/phosphatidylserine (PS), which is quite distinct
from lipid compositions in the stratum corneum layer.
The stratum corneum, the thin, outer dead layer of
the epidermis, is the main barrier to percutaneous
absorption of most chemicals.1 Hence, the use of ap-
propriate liposomes to mimic the stratum corneum
lipids is of vital importance.
To compare different partitioning systems (includ-
ing biological and artificial ones) and unravel the
structural determinants governing the partitioning of
solutes in these systems, we use the Abraham linear
free energy relationship (LFER)11–13:
SP = c + eE + sS+ aA + bB + vV (1)
where E, S, A, B, and V are solute descriptors. E is
the excess molar refraction in (cm3 mol−1)/10, S is the
solute dipolarity/polarizability, A and B are the over-
all solute hydrogen bond acidity and hydrogen bond
basicity, and V is the McGowan characteristic volume
of the solute in (cm3 mol−1)/100. SP represents a set
of solute properties in a given system, for example,
SP could be the n-octanol–water distribution coeffi-
cient log Doct, the skin permeability log Kp, or the re-
tention factor log k in LEKC for a series of solutes.
Equation 1 has been successfully tested in a wide
range of systems, including a large number of par-
titions from water to organic solvent,12,14,15 various
artificial membrane models,9,13,16 as well as biologi-
cal processes.17–19 The coefficients in Eq. 1 (c, e, s, a,
b, and v) are obtained by multiple linear regression
(MLR) analysis and are used to characterize the given
system.
In the present study, all the measurements were
performed at pH 7.4, where some of the solutes sum-
marized in Table 1 are present as ionic species: cations
from protonated amines and anions from deproto-
nated carboxylic acids. Equation 1 was set up for neu-
tral solutes only12–19 and to extend it to ionic species
Abraham and Acree20–23 developed Eq. 2. This equa-
tion contains the same five descriptors as in Eq. 1,
together with a new descriptor for cations, J+, and a
new descriptor for anions, J−.
SP =c + eE + sS+ aA + bB + vV + j+J+ + j−J− (2)
Note that J+ = 0 for anions, J− = 0 for cations, and
both J+ and J−= 0 for neutral compounds. In other
words, Eq. 2 reverts to Eq. 1 when Eq. 2 is constructed
only for neutral species.
The aims of the present work are to measure LEKC
retention factors in the presence of cerasome, a ma-
terial that closely resembles stratum corneum lipids,
and to investigate the possibility of constructing an
LFER equation for the LEKC retention factors as
a necessary preliminary to assess the LEKC system
(called cerasome EKC system in this work) as a model
for skin permeation, especially with respect to the




The (4-methylbenzyl)alkylamines were synthesized
according to known procedures.24 All other com-
pounds in Table 1 were obtained from Sigma–Aldrich
(Steinheim, Germany) and were of highest avail-
able purity. Sodium dihydrogen phosphate and dis-
odium hydrogen phosphate were purchased from
Sigma–Aldrich, methanol (high-performance liquid
chromatography grade) was purchased from Carl
Roth (Karlsruhe, Germany), and decanophenone was
from Alfa Aesar (Karlsruhe, Germany).
Cerasome (product name: Cerasome 9005) was
kindly donated by Lipoid GMBH (Ludwigshafen, Ger-
many). This cerasome is composed of hydrogenated
lecithin, cholesterol, ceramides (NP and NS), and
fatty acids (palmitic acid and oleic acid) in distilled
water with a small amount of ethanol as preservative
(around 10%). The concentration of the total lipids is
6.60 (g/100g). The particle size and pH value of cera-
some offered by Lipoid GMBH are 48.1 nm and 7.3,
respectively. The cerasome was stored between 15◦C
and 25◦C, as recommended in the product information
sheet.
Preparation of Cerasome Dispersion Used in LEKC
Cerasome was diluted 50 times with 10 mM phos-
phate buffer (pH 7.4). The diluted cerasome dis-
persion was filtered (200 nm, nylon; MedChrom,
Flörsheim-Dalsheim, Germany) at room tempera-
ture. The average particle size and the zeta poten-
tial of filtered cerasome measured using a Zetasizer
Nano ZS (Malvern, Herrenberg, Germany) were 49.5
(±0.5) nm with polydispersity index of 0.105 and
–68.0 (±1.0) mV, respectively. Cerasome dispersion
(150 mL) was prepared once as described above and
utilized in all the cerasome EKC experiments.
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k7.4c Ed Sd Ad Bd Vd J+d J−d
1 Cortexolone N Neutral 2.52 2.52 −1.11 1.910 3.45 0.36 1.60 2.7389 0.0000 0.0000
2 Cortexone N Neutral 2.88 2.88 −0.82 1.740 3.50 0.14 1.31 2.6802 0.0000 0.0000
3 Corticosterone N Neutral 1.94 1.94 −1.27 1.860 3.43 0.40 1.63 2.7389 0.0000 0.0000
4 Cortisone N Neutral 1.47 1.47 −1.57 1.960 3.50 0.36 1.87 2.7546 0.0000 0.0000
5 Dexamethasone N Neutral 1.83 1.83 −1.40 2.040 3.51 0.71 1.92 2.9132 0.0000 0.0000
6 Digitoxin N Neutral 1.86 1.86 −1.12 3.460 5.56 1.67 4.35 5.6938 0.0000 0.0000
7 Estriol N Neutral 2.54 2.54 −1.37 1.970 1.74 1.06 1.63 2.2575 0.0000 0.0000
8 Hydrocortisone N Neutral 1.55 1.55 −1.47 2.030 3.49 0.71 1.90 2.7976 0.0000 0.0000
9 Hydrocortisone-21-acetate N Neutral 2.19 2.19 −1.41 1.890 2.88 0.46 2.16 3.0951 0.0000 0.0000
10 17-Hydroxyprogesterone N Neutral 3.17 3.17 −0.90 1.640 3.35 0.25 1.31 2.6802 0.0000 0.0000
11 Prednisolone N Neutral 1.62 1.62 −1.50 2.210 3.10 0.71 1.92 2.7546 0.0000 0.0000
12 Testosterone N Neutral 3.29 3.29 −0.85 1.540 2.59 0.32 1.19 2.3827 0.0000 0.0000
13 Bibenzyl N Neutral 4.80 4.80 0.72 1.220 1.04 0.00 0.33 1.6060 0.0000 0.0000
14 4-Chloro-2-methylphenol 9.60 Neutral 2.78 2.78 −0.74 0.890 0.91 0.63 0.22 1.0384 0.0000 0.0000
15 4-Chloro-3,5-dimethylphenol 9.70 Neutral 3.27 3.27 −0.51 0.925 0.96 0.64 0.21 1.1793 0.0000 0.0000
16 3,4-Dimethylphenol 10.32 Neutral 2.23 2.23 −1.34 0.830 0.90 0.55 0.38 1.0569 0.0000 0.0000
17 1-Fluoro-2,4-dinitrobenzene N Neutral 1.47 1.47 −1.63 1.006 1.69 0.00 0.45 1.0825 0.0000 0.0000
18 2-Naphthol 9.57 Neutral 2.70 2.70 −0.70 1.520 1.08 0.61 0.40 1.1441 0.0000 0.0000
19 Resorcinol 9.15 Neutral 0.80 0.79 −1.49 0.980 1.11 1.09 0.52 0.8338 0.0000 0.0000
20 Styrene N Neutral 2.95 2.95 −0.62 0.849 0.65 0.00 0.16 0.9552 0.0000 0.0000
21 Toluene N Neutral 2.73 2.73 −0.83 0.601 0.52 0.00 0.14 0.8573 0.0000 0.0000
22 4-BrC6H4OH 9.31 Neutral 2.59 2.58 −0.87 1.080 1.17 0.67 0.20 0.9501 0.0000 0.0000
23 3-CH3C6H4OH 10.09 Neutral 1.96 1.96 −1.48 0.822 0.88 0.57 0.34 0.9160 0.0000 0.0000
24 4-CH3C6H4OH 10.26 Neutral 1.95 1.95 −1.43 0.820 0.87 0.57 0.31 0.9160 0.0000 0.0000
25 C6H5COCH3 N Neutral 1.58 1.58 −1.64 0.818 1.01 0.00 0.48 1.0139 0.0000 0.0000
26 2-ClC6H4NH2 2.64 Neutral 1.91 1.91 −1.50 1.033 0.92 0.25 0.31 0.9390 0.0000 0.0000
27 2-ClC6H4NO2 N Neutral 2.52 2.52 −1.27 1.020 1.24 0.00 0.24 1.0130 0.0000 0.0000
28 3-ClC6H4OH 9.11 Neutral 2.50 2.49 −1.05 0.909 1.06 0.69 0.15 0.8975 0.0000 0.0000
29 4-ClC6H4OH 9.40 Neutral 2.39 2.39 −1.01 0.915 1.08 0.67 0.20 0.8975 0.0000 0.0000
30 4-ClC6H4CH2OH N Neutral 1.96 1.96 −1.36 0.911 0.96 0.40 0.50 1.0384 0.0000 0.0000
31 2-H2NC6H4Ph 3.82 Neutral 2.84 2.84 −1.06 1.600 1.48 0.26 0.41 1.4240 0.0000 0.0000
32 3-O2NC6H4OH 8.40 Neutral 2.00 1.96 −0.83 1.050 1.57 0.79 0.23 0.9493 0.0000 0.0000
33 PhCH2CN N Neutral 1.56 1.56 −1.61 0.751 1.03 0.00 0.50 1.0120 0.0000 0.0000
34 PhCH2OH N Neutral 1.10 1.10 −1.66 0.803 0.87 0.39 0.56 0.9160 0.0000 0.0000
35 PhNH2 4.60 Neutral 0.90 0.90 −1.73 0.955 0.96 0.26 0.41 0.8162 0.0000 0.0000
36 PhNHEt 5.12 Neutral 2.16 2.16 −1.52 0.945 0.85 0.17 0.43 1.0980 0.0000 0.0000
37 PhNO2 N Neutral 1.85 1.85 −1.49 0.871 1.11 0.00 0.28 0.8906 0.0000 0.0000
38 PhOH 9.95 Neutral 1.47 1.47 −1.56 0.805 0.89 0.60 0.30 0.7751 0.0000 0.0000
39 Acridine 5.58 Neutral 3.40 3.39 −0.51 2.356 1.32 0.00 0.58 1.4133 0.0000 0.0000
40 Aspirin 3.48 Anion 1.13 −2.79 −2.20 0.931 3.91 0.04 3.03 1.2664 0.0000 2.1227
41 Flurbiprofen 3.91 Anion 3.81 0.32 −1.21 1.590 4.56 0.07 3.36 1.8174 0.0000 2.5383
42 Ibuprofen 4.43 Anion 3.87 0.90 −1.19 0.880 3.50 0.08 3.31 1.7556 0.0000 2.4188
43 Ketoprofen 4.29 Anion 2.77 −0.34 −1.32 1.800 5.49 0.01 3.39 1.9564 0.0000 2.4851
44 Mefenamic acid 4.33 Anion 5.12 2.05 −1.17 1.800 4.71 0.09 3.14 1.8996 0.0000 2.6427
45 Naproxen 4.15 Anion 3.06 −0.19 −1.43 1.660 5.07 0.02 3.11 1.7606 0.0000 2.4260
46 4-BrC6H4COOH 3.97 Anion 2.86 −0.57 −1.16 1.150 3.47 0.04 2.61 1.0852 0.0000 2.2504
47 1-C10H7COOH 3.69 Anion 3.10 −0.61 −1.61 1.610 4.13 0.05 2.87 1.2792 0.0000 2.4041
48 3-ClC6H4COOH 3.83 Anion 2.71 −0.86 −1.58 0.990 3.25 0.04 2.68 1.0326 0.0000 2.2010
49 4-ClC6H4COOH 3.98 Anion 2.65 −0.77 −1.39 0.990 3.31 0.04 2.60 1.0326 0.0000 2.1873
50 4-IC6H4COOH 3.96 Anion 3.13 −0.31 −1.32 1.460 4.00 0.03 2.63 1.1684 0.0000 2.3116
51 C6H5COOH 4.20 Anion 1.96 −1.24 −1.16 0.880 3.05 0.02 2.75 0.9102 0.0000 2.1385
52 C6H5(CH2)2COOH 4.25 Anion 1.89 −1.26 −1.37 0.900 3.43 0.03 3.02 1.1920 0.0000 2.1879
53 C6H5(CH2)3COOH 4.72 Anion 2.42 −0.26 −1.67 0.910 3.59 0.04 3.01 1.3329 0.0000 2.2184
54 C6H5(CH2)4COOH 4.55 Anion 2.85 0.00 −1.63 0.920 3.63 0.04 3.10 1.4718 0.0000 2.2794
55 C6H5(CH2)7COOH 5.03 Anion 4.09 1.72 −1.31 0.940 3.87 0.07 3.26 1.8965 0.0000 2.4256
56 4-MeC6H4CH2NHMe 9.93 Cation 1.96 −0.57 −0.63 0.630 2.64 1.47 0.00 1.2604 1.2622 0.0000
57 4-MeC6H4CH2NHEt 10.04 Cation 2.38 −0.26 −0.63 0.610 2.69 1.48 0.00 1.4013 1.2647 0.0000
58 4-MeC6H4CH2NHPr 9.98 Cation 2.96 0.38 −0.56 0.590 2.68 1.45 0.00 1.5422 1.2605 0.0000
59 4-MeC6H4CH2NHBu 9.98 Cation 3.49 0.91 −0.44 0.570 2.68 1.46 0.00 1.6831 1.2405 0.0000
60 4-MeC6H4CH2NH(CH2)4Me 10.08 Cation 4.26 1.58 −0.08 0.550 2.66 1.41 0.00 1.8240 1.2522 0.0000
61 4-MeC6H4CH2NH(CH2)5Me 10.17 Cation 4.96 2.19 0.26 0.540 2.45 1.29 0.00 1.9649 1.2268 0.0000
62 4-MeC6H4CH2NH(CH2)6Me 10.02 Cation 5.12 2.50 0.95 0.530 2.51 1.47 0.00 2.1058 1.1215 0.0000
Continued
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k7.4c Ed Sd Ad Bd Vd J+d J−d
63 Acebutolol 9.52 Cation 2.02 −0.10 −1.01 1.450 6.69 3.62 0.00 2.7771 2.2965 0.0000
64 Alprenolol 9.59 Cation 3.10 0.91 0.06 1.100 4.46 1.78 0.00 2.1802 2.2574 0.0000
65 Metoprolol 9.63 Cation 1.95 −0.28 −0.79 1.020 5.35 2.16 0.00 2.2819 2.3476 0.0000
66 Oxprenolol 9.57 Cation 2.51 0.34 −0.50 1.160 5.09 2.35 0.00 2.2389 2.2029 0.0000
67 Penbutolol 9.92 Cation 4.62 2.10 0.74 0.775 4.66 1.98 0.00 2.6195 1.9630 0.0000
68 Pindolol 9.54 Cation 1.75 −0.39 −0.83 1.550 4.60 2.36 0.00 2.0305 2.2661 0.0000
69 Propafenone 9.62 Cation 3.64 1.42 0.45 1.550 5.67 2.97 0.00 2.8467 2.3467 0.0000
70 Propranolol 9.53 Cation 3.48 1.35 0.47 1.690 4.31 2.07 0.00 2.1695 2.4319 0.0000
71 Timolol 9.21 Cation 1.83 0.01 −0.82 1.320 5.67 2.83 0.00 2.3974 2.2692 0.0000
aTaken from Refs. 31, 32 and Bioloom Software (Version 1.5; Biobyte Corporation, Claremont, U.S.A).
bCalculated according to log D = log Poct − log (1+ 10pKa − pH) for bases and log D = log Poct − log (1+ 10pH − pKa) for acids.
cCalculated from retention time data using Eqs. 3 and 4; n = 3, s.d ≤ 0.01 for neutrals and bases, and s.d ≤ 0.05 for acids.
dTaken from Refs. 20–23, or calculated from the equations in Ref. 21.
Storage of Cerasome Dispersion
Cerasome vesicles dispersed in 10 mM phosphate
buffer (pH 7.4) were unstable between 15◦C and
25◦C (the storage temperature for original cerasome).
During storage, the average particle size increased
slightly 24 h after dilution of the cerasome product
and cerasome aggregates were observed. Therefore,
the cerasome dispersion was stored at 4◦C (the gen-
eral storage temperature of liposome).25 Under these
conditions, the cerasome dispersion was stable for at
least 14 days determining the particle size before the
cerasome EKC experiments each day.
Capillary Electrophoresis Apparatus
The cerasome EKC experiments were carried out
on a HPCE 1600AX (Agilent, Waldbronn, Germany)
equipped with a diode array detector. An uncoated
fused silica capillary of 50:m inner diameter (ID)
and 375:m outer diameter (OD), with a total length
of 58.5 cm (50 cm in effective length to the detector)
was used throughout the study. The samples were
analyzed at an applied positive voltage of 20 kV, at a
temperature of 37◦C. Sample injection was performed
hydrodynamically at 50 mbar for 3 s. Detection wave-
lengths were 210, 225, and 245 nm. Methanol was
used as electroosmotic flow marker and decanophe-
none was used as liposome marker.26,27 The prepared
cerasome dispersion and 10 mM phosphate buffer (pH
7.4) were used as the running solutions, respectively,
in the cerasome EKC and capillary zone electrophore-
sis (CZE) systems.
LEKC Procedures
A new fused silica capillary was pretreated for 15 min
with 1.0 M NaOH, 5 min with Milli-Q water, 15 min
with 1.0 M HCl, and 5 min with Milli-Q water. In or-
der to equilibrate the physical absorption of cerasome
vesicles on the inner wall, the capillary was rinsed
for 30 min each day with the cerasome dispersion be-
fore sample injections were performed.26 At the end of
each day, the capillary was rinsed with 10 mM phos-
phate buffer (pH 7.4) at 50 mbar overnight.
For charged solutes, the retention time tr (from
LEKC) in the presence of cerasome, and the retention
time t0 (from CZE) in the absence of cerasome were
determined in order to calculate the retention factor
k, as described by Eq. 3, whereas only LEKC mea-
surements are needed for neutral solutes, as shown
by Eq. 4:27














where tr, teo, and tlip are the retention times of the so-
lute, the electroosmotic flow marker (methanol), and
the cerasome marker (decanophenone) in cerasome
EKC system, respectively; t0 is the retention time
of ionized solutes in the bulk aqueous phase (CZE;
buffer solution without cerasomes); the retention fac-
tor log k can be regarded as a lipophilicity index in
the liposome –water system because the log k value
of a solute is linearly related to its partition coeffi-
cient between the aqueous phase and the liposome
phase.28 The equation for calculating the retention
factors of ionizable solutes is different from that for
neutral solutes, owing to the fact that migration of
charged solutes in LEKC system involves the elec-
trophoretic mobility in the aqueous phase as well as
their interaction with liposome carriers, but migra-
tion of neutral solutes is only related to their parti-
tion with liposome.27 Thus, the retention time of so-
lutes in the aqueous buffer without cerasome (CZE)
was considered as the unretained time instead of the
migration time of the electroosmotic flow marked by
methanol for ions.
The log k measurements of all the solutes were
repeated three times. Before sample injection, the
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capillary was rinsed for 3 min with the correspond-
ing running solution (buffer solution or cerasome dis-
persion). CZE measurements for each charged solute
were carried out immediately following LEKC mea-
surements after rinsing the capillary with buffer solu-
tion for 3 min.26 This was performed in order to main-
tain cerasome vesicles absorbed to the inner capillary
wall so that CZE experiments were performed under
the same wall conditions.29,30
Solutes were dissolved in methanol to prepare stock
solutions, which were diluted with the correspond-
ing running solution before injection to approximately
2.0–3.0 × 10−4 mol L–1. Decanophenone dissolved in
methanol was added where appropriate, as the cera-
some maker. All solutions were filtered (200 nm) prior
to use.
RESULTS AND DISCUSSION
A set of 71 compounds with a broad structural di-
versity was selected and their retention factors, log
k7.4, were determined using cerasome EKC. The
log k7.4 values and other physicochemical parame-
ters, including acid dissociation constants pKa,31,32
n-octanol–water distribution coefficients at pH 7.4,
log D7.4, n-octanol–water partition coefficients, log
Poct,31,32 as well as the values of the solute descrip-
tors are shown in Table 1. The space distributions of
structural parameters (E, S, A, B, and V) are shown
in Figure 1. As J+ and J− specific to ions have no ex-
act physicochemical definition, they are not discussed
here.
Abraham33 has recently shown that Eq. 2 can be ap-
plied to the permeation of neutral molecules and ionic
species from saline through the blood–brain barrier.
We follow exactly the same procedure. Appropriate
solute descriptors were used for whatever species is
present at pH 7.4, as shown in Table 1. Abraham and
Acree20–23 have obtained solute descriptors for many
anions derived from acids by deprotonation and for
many cations derived from bases by addition of a pro-
ton. In cases where the descriptors were not deter-
mined, we used the equations set out by Abraham
and Acree21 for the calculation of descriptors. Once
descriptors for the relevant species are available, the
dependent variable, in this case log k7.4, can be re-
gressed against them for the LFER model. Thus to re-
veal the solute factors that influence the partitioning
of chemicals in cerasome EKC system, the MLR of log
k7.4 against the solute descriptors yielded the LFER
model that includes both neutral and ionic species, as
follows:
log k7.4 = −1.922 (±0.258) + 0.200 (±0.245) E
−0.629 (±0.179) S− 0.109 (±0.236) A
−1.451 (±0.328) B + 1.757 (±0.320) V
+0.334 (±0.356) J+ + 1.958 (±0.400) J−
N = 71, R2 = 0.814, SD = 0.293, F = 39 (5)
In this and the following equations, 95% confidence
limits are given in parentheses; N is the number of
compounds, R is the correlation coefficient, SD is the
standard deviation, and F is the Fisher’s test. The
standardization of Eq. 5 gives the relative contribu-
tions of each variable to the total LFER model, which
is 3.67% for E, 26.13% for S, 1.15% for A, 24.59% for
B, and 44.45% for V, indicating that the significant
factors influencing partitioning in cerasome EKC are
S, B, and V, whereas E and A are of no statistical sig-
nificance. Eq. 6 shows the LFER model when E and
A are removed.
log k7.4 = −1.844 (±0.218) − 0.587 (±0.166) S
−1.427 (±0.326) B + 1.782 (±0.322) V
+0.164 (±0.289) J+ + 1.912 (±0.373) J−
N = 71, R2 = 0.803, SD = 0.297, F = 53 (6)
Figure 1. Space distributions of structural parameters for the selected set of 71 compounds.
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Table 2. Coefficients in Eq. 2 for Partition Between Water and Solvents
Solvent No. c e s a b v j+ j–
Methanol 1 0.276 0.334 −0.714 0.243 −3.320 3.549 −2.609 3.027
Ethanol 2 0.222 0.471 −1.035 0.326 −3.596 3.857 −3.170 3.085
1-Propanol 3 0.139 0.405 −1.029 0.247 −3.767 3.986 −3.077 2.834
1-Butanol 4 0.152 0.438 −1.177 0.096 −3.919 4.122 −3.605 2.685
1-Hexanol 5 0.115 0.492 −1.164 0.054 −3.971 4.131 −3.100 2.940
Propanone 6 0.313 0.312 −0.121 −0.608 −4.753 3.942 −2.288 0.078
Acetonitrile 7 0.413 0.077 0.326 −1.566 −4.391 3.364 −2.243 0.101
NMP 8 0.147 0.532 0.275 0.840 −4.794 3.674 −1.797 0.105
DMSO 9 −0.194 0.327 0.791 1.260 −4.540 3.361 −3.387 0.132
EG 10 −0.270 0.578 −0.511 0.715 −2.619 2.729 −1.300 2.363
PC 11 0.004 0.168 0.504 −1.283 −4.407 3.421 −1.989 0.341
Wet 1-octanol, log P 12 0.088 0.562 −1.054 0.034 −3.460 3.814 −3.023 2.580
Wet 1-octanol, log D7.4 13 −0.027 0.868 −1.053 −0.257 −3.383 3.577 −1.438 3.389





As J+ and J− are specific to ions, they were excluded
in the contribution calculation for log k7.4 values of
the whole set. The relative contribution of J+ could
be calculated while considering only cations, that is,
compounds #56–71, whereas that of J− could be cal-
culated while considering only anions, that is, com-
pounds #40 –55.In Eq. 5, the relative contributions of
J+ and J− are 8.37% and 32.26%, respectively, which
indicates that the importance of J+ for cationic par-
titioning is much lower than that of J− for anionic
partitioning in cerasome EKC system.
It is of considerable interest to compare retention
factors for neutral compounds that are ionizable with
those for the corresponding anions or cations. We have
measured log k7.4 for 16 anions derived from car-
boxylic acids and we are now in a position to use Eq.
5 to calculate for the 16 neutral carboxylic acids, us-
ing descriptors for the neutral species. These can then
be compared with log k7.4 for the anions. Over the 16
compounds, the average difference log k (neutral car-
boxylic acids) – log k7.4 (carboxylate anions) = 0.60
log units, so that on average the retention factor for
the neutral carboxylic acids is four times that for the
carboxylate anions. In the case of 16 protonated base
cations, the average difference log k (neutral base) –
log k7.4 (protonated base cation) = –0.44 log units, so
that the retention factor for the neutral bases is only
0.36 times that for the protonated base cations. This
is a particularly important example of the extra infor-
mation that can be obtained by LFER methods when
LFERs using descriptors for ionic species are applied.
To compare the factors that influence the cera-
some EKC system with those in the traditional n-
octanol–water system, the LFER model was also ap-
plied to the distribution coefficients (log D7.4) of the
same set, yielding Eq. 7:
log D7.4 = −0.027 (±0.368) + 0.868 (±0.350) E
−1.053 (±0.256) S− 0.257 (±0.337) A
−3.383 (±0.468) B + 3.577 (±0.456) V
−1.438 (±0.509) J+ + 3.389 (±0.572) J−
N = 71, R2 = 0.919, SD = 0.419, F = 102 (7)
with the relative contributions of 7.35% for E, 20.82%
for S, 1.29% for A, 27.27% for B, and 43.05% for V.
The relative contributions of J+ and J− for log D7.4
are 16.63% and 27.84% for ionized solutes, respec-
tively. After removal of the term A with no statistical
significance, Eq. 8 was obtained:
log D7.4 = −0.089 (±0.362) + 0.870 (±0.354) E
−1.085 (±0.255) S− 3.424 (±0.470) B
+3.601 (±0.460) V − 1.643 (±0.436) J+
+3.503 (±0.557) J−
N = 71, R2 = 0.916, SD = 0.423, F = 116 (8)
A very useful way to compare the coefficients in a
set of equations is to carry out a principle components
analysis (PCA). The seven coefficients in equations of
the type of Eq. 2 were transformed into seven princi-
ple components that contain exactly the same infor-
mation, but which are orthogonal to each other. The
comparison of the systems is shown in Table 2.22,23
The first two principle components contain 75% of the
total information. A plot of the scores of PC2 against
PC1 will reveal how “close” the equations are in terms
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Figure 2. Plot of the scores of PC2 against the scores of
PC1 for the coefficients of the equations in Table 2. PC1 and
PC2 are the first two principle components from principle
component analysis for these coefficients.
of chemical interactions (see Fig. 2). As might be ex-
pected, the points for the hydroxylic solvents, #1–5,
#10, and #12, cluster together. Perhaps surprisingly,
log D7.4 is quite close to this group. The aprotic sol-
vents, #6–9 and #11, form a quite separate cluster.
Very interestingly, the point (#14) for the cerasome log
k7.4 coefficients is far away from all the other points on
the PC2 versus PC1 plot, so that the cerasome log k7.4
data leads to a quite new model for the comparison
of uptake from water to organic phases. In future, we
shall investigate the cerasome model for the analysis
of skin permeation.
The coefficients c–v for partitioning of neutral
molecules and ionic species from water to wet
octanol23 were constrained to be exactly the same as
the coefficients in the corresponding equation for neu-
tral species. We should therefore expect that our equa-
tion for log D7.4 would also have the same coefficients,
c--v. Within reasonable experimental error, this is the
case, see Table 2.
From our previous equations, it can be seen that
both J+ and J− have a significant effect on partition-
ing of charged compounds in cerasome EKC andn-
octanol-water systems, although values of the coeffi-
cients are completely different. This implies that the
different contributions of the terms j+ × J+ and j−
× J− in these two partitioning systems might be the
biggest difference between them. To confirm this, a
plot of log k7.4 against log D7.4 was constructed. As
shown in Figure 3, the data points for neutrals, an-
ions, and cations lie on three distinct lines, with no
direct correlation existing between log k7.4 and log
D7.4 for the whole set of compounds (R2 = 0.117). This
also indicates that the charge factor of the solutes
plays a crucial role on the difference of partitioning
mechanisms in both systems. Thus, a MLR of log k7.4
against log D7.4 and the ionic descriptors was carried
out as shown in Eq. 7:
log k7.4 = 0.372 (±0.089) log D7.4 + 0.743 (±0.129) J+
+0.262 (±0.0128) J− − 1.948 (±0.225)
N = 71, R2 = 0.712, SD = 0.354, F = 55 (9)
As expected, this equation shows a significant im-
provement on the correlation between log k7.4 and
log D7.4, where R2 = 0.117 over all solutes. This also
demonstrates the necessity of addition of the ionic
descriptors in LFER models.
CONCLUSION
Liposome electrokinetic chromatography is a pow-
erful tool for investigating the interactions between
chemicals and lipid bilayers. In this study, the re-
tention factors of 71 solutes including neutral and
ionic species were determined using a LEKC system,
where cerasome was used as the liposome material.
The developed Abraham LFER model was applied to
Figure 3. Correlation between the retention factors log k7.4 in cerasome EKC and the
n-octanol–water distribution coefficients log D7.4 for all solutes.
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the retention factors by MLR analysis. The resulting
LFER model revealed the structural parameters S,
B, and V as the three prominent factors in cerasome
EKC system, whereas the effects of E and A are of mi-
nor importance or even negligible. A detailed analysis
showed that the retention factors for neutral acids are
about four times that for carboxylate anions, whereas
the factor is only 0.36 times for neutral bases as com-
pared with the protonated base cations. A compari-
son between the LFER models for log k7.4 and various
water–organic solvent partitions revealed that log k7.4
reflects quite different solute interactions. Therefore,
it could provide the basis of a new model, possibly
for skin permeation. The relationship between log
k7.4 and log D7.4 is very poor but is considerably im-
proved by the incorporation of descriptors for ionic
partitioning.
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ABSTRACT: The permeability, Kp, of some ionized solutes (including nine acids and nine
bases) through human epidermis membrane was measured in this work. Combined with the
experimental Kp data set for neutral species created by Abraham and Martins and reliable Kp
data for ionic species from the literature, a linear free-energy relationship (LFER) analysis was
conducted. The values of log Kp for 118 compounds have been correlated with solute descriptors
to yield an LFER equation that incorporates neutral species and ionic species, with R2 = 0.861
and SD = 0.462 log units. The equation can be used to predict Kp for neutral species and
ionic species, as well as partly ionized solutes. Predicted values for the passive permeation
of the sodium ion and the tetraethylammonium ion are in good accord with the experimental
values. It was observed that neutral acids and bases are more permeable than their ionized
forms, and that the ratio depends on the actual structure. The correlation between human
skin permeation and water–organic solvent/artificial membrane partitions was investigated by
comparison of the coefficients in the LFER equations. Partition into cerasome is a reasonable
model for partition into skin, and using cerasome as a surrogate for the partitioning process, we
separate permeation into partition and diffusion processes. We show that the poor permeability
of ionic species is largely due to slow diffusion through the stratum corneum. This is especially
marked for a number of protonated base cations. © 2012 Wiley Periodicals, Inc. and the American
Pharmacists Association J Pharm Sci 101:2034–2044, 2012
Keywords: transdermal drug delivery; permeability; skin; permeation; partition; diffusion;
ionic species; physicochemical properties; linear free-energy relationship; LFER; QSPR
INTRODUCTION
Much work on physicochemical models for drug per-
meation through human skin has been carried out
using the n-octanol/water partition coefficient (log
Poct) as a lipophilicity index plus molecular weight
(or volume).1 However, these models were just built
on human skin permeability (Kp) data sets for neu-
tral solutes, and in some cases, ionization of basic
and acidic compounds was ignored selectively. This
is due to the fact that it is extremely difficult to
construct an equation incorporating neutral species
Correspondence to: Xiangli Liu (Telephone: +49-3641-949903;
Fax: +49-3641-949902; E-mail: xiangli.liu@uni-jena.de); Michael
H. Abraham (Telephone: +44-20-7679-4639; Fax: +44-20-7679-
7463; E-mail: m.h.abraham@ucl.ac.uk)
Journal of Pharmaceutical Sciences, Vol. 101, 2034–2044 (2012)
© 2012 Wiley Periodicals, Inc. and the American Pharmacists Association
and ionic species for skin permeation. On the one
hand, ionizable species can exist both as separate
ions (anions and cations) and as ion pairs in octanol;
the experimentally measured log Poct values for the
separated ions are those for a neutral combination
of anions and cations and single ion log Poct values
have to be obtained using some extrathermodynamic
convention.2 On the other hand, log Poct, as a widely
used lipophilicity index, could not encode some impor-
tant recognition forces between charged solutes and
biological membranes. In our study, the term “ions”
refer to permanent ions such as Na+ and Cl−, and
the term “ionic species” refers to ions derived from
protonation of basic compounds and deprotonation of
acidic compounds.
One feasible method for the prediction of Kp for
ions and ionic species is through the linear free-
energy relationship (LFER) proposed by Abraham.
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The general LFER equation, Eq. 1, has been success-
fully applied to a large number of equilibrium sys-
tems, including water–solvent partitions,3–5 water–
artificial membrane partitions,6–9 and biological
membrane permeations.10–12 Nevertheless, Eq. 1 was
established to deal with processes that involved only
neutral solutes. In order to extend Eq. 1 to include
ions and ionic species, Abraham and Acree13 incor-
porated an additional term j+J+ for cations and an
additional term j−J− for anions, as shown in Eq. 2:
SP = c + eE + sS+ aA + bB + vV (1)
SP = c + eE + sS+ aA + bB + vV + j+J+ + j−J− (2)
Here and elsewhere, the dependent variable SP
represents a property of a series of solutes in a given
system, including partition coefficients (e.g., log Poct)
and rate coefficients (e.g., log Kp). The independent
variables are the solute descriptors as follows: E is
the excess molar refraction in units of (cm3/mol)/10,
S is the combined dipolarity/polarizability, A and B
are the overall solute hydrogen bond acidity and ba-
sicity, and V is McGowan’s characteristic molecular
volume in units of (cm3/mol)/100; J+ and J− are the
additional descriptors that refer to the ion–solvent in-
teraction for cations and anions, respectively. That is
to say, J+ is zero for anions, J− is zero for cations, and
both of them are zero for neutral species. The meth-
ods of computation or estimation of the seven solute
descriptors have been detailed previously.14 The co-
efficients in Eq. 2 are obtained using multiple linear
regression analysis and serve to characterize the sys-
tem of interest.
Equation 2 has been proved to be a good model that
includes both neutral species and ionic species for the
partition of solutes in water/organic solvents,2,13,15
and in water/liposome (cerasome),16 as well as the
permeation through the blood–brain barrier.14
Previously, Eq. 1 was applied to observed log Kp
of 119 neutral solutes,11 leading to Eq. 3, with Kp in
units of cm s−1:
log Kp = −5.426 − 0.106E − 0.473S− 0.473A
−3.000B + 2.296V (3)
Now that descriptors can be estimated for ionic
species, Eq. 3 can be extended to include both species,
thus leading to a model for the prediction of skin per-
meation of ions and ionic species as well as neutral
species, from known solute descriptors. The aim of
this study is to set up an LFER model for human skin
permeation of neutral and ionic species. To achieve
this aim, we have measured the log Kp values for 18
ionized solutes through human epidermis, and have
combined these data with literature log Kp values in
order to derive such an LFER model.
MATERIALS AND METHODS
Chemicals
A series of (4-methylbenzyl)alkylamines hydrochlo-
ride was synthesized according to a known
procedure.17 All other compounds shown in Table 1 as
well as potassium dihydrogen phosphate and dipotas-
sium hydrogen phosphate were purchased from
Sigma–Aldrich (Steinheim, Germany) and were of
highest available purity. Methanol and acetonitrile
[high-performance liquid chromatography (HPLC)
gradient grade] used in HPLC measurements were
purchased from BDH Prolabo (VWR, Dresden,
Germany).
Measurement of Solubility
The solutes in Table 1 were added to 0.02 M phosphate
buffer (pH 7.4) until saturation occurs, indicated by
undissolved excess solute. The resulting suspension
was stirred with a magnetic bar overnight in an air
bath of 32◦C by using an incubator. The sample was
rapidly filtered to remove the undissolved material
by using a syringe filter (200 nm, nylon; MedChrom,
Flörsheim-Dalsheim, Germany). The concentration of
the saturated solution (solubility of the solute) was
determined by HPLC analysis.
Epidermis Preparation
Human abdominal skin was obtained from women
aged 30–50 years old and subjected to plastic surgery.
The subcutaneous fatty tissue was removed from the
skin using disposable scalpels and surgical scissors
with curved blade within 2 h after operation, and then
the remaining full-thickness skin was frozen at −20◦C
with aluminum foil packing as soon as possible, for 3-
month usage. Before permeation experiments for each
compound, some frozen skin disks of 25 mm diameter
were punched out and thawed at room temperature,
followed by a water bath at 60◦C for 90 s. The epider-
mis sheets were separated by scratching the connec-
tive part between dermis and epidermis with tooth-
less tweezers. These epidermis sheets were bathed in
the receptor medium for at least 30 min prior to use.
In Vitro Permeation Studies
The in vitro permeation studies were conducted for
the compounds in Table 1. The epidermis sheet was
mounted in a single-wall Franz cell (Gauer Glas,
Püttlingen, Germany) with an effective diffusion
area of 1.76 cm2 and a receptor chamber of 12 mL,
following a visual check for skin integrity with a
magnifier. In skin permeation experiments, 0.02 M
phosphate buffer pH 7.4 was used as the donor
and receptor medium. The donor solution for each
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Table 1. Experimental Values of Log Kp at 32◦C for the Compounds Used in This Work, and Other Physicochemical Parameters
No. Compound Log Pocta Solubilityb pKaa pH (Obs) Fnc Fic Log Kpd (Obs)
1 C6H5COOH 1.96 4.78 4.20 3.97 0.629 0.371 −5.31 ± 0.02
2 C6H5(CH2)2COOH 1.89 11.85 4.52 4.16 0.696 0.304 −5.28 ± 0.01
3 C6H5(CH2)3COOH 2.42 4.81 4.72 5.00 0.344 0.656 −5.50 ± 0.06
4 C6H5(CH2)4COOH 2.85 3.29 4.55 6.01 0.034 0.966 −5.82 ± 0.02
5 C6H5(CH2)7COOH 4.09 1.54 5.03 6.84 0.015 0.985 −5.60 ± 0.05
6 Flurbiprofen 3.81 2.75 3.91 6.75 0.001 0.999 −6.20 ± 0.02
7 Ibuprofen 3.87 2.57 4.43 6.61 0.007 0.993 −6.03 ± 0.02
8 Ketoprofen 3.12 3.89 4.29 6.42 0.007 0.993 −5.71 ± 0.06
9 Naproxen 3.06 2.68 4.15 6.71 0.003 0.997 −6.73 ± 0.03
10 4-MeC6H4CH2NHMe 1.96 – 9.93 7.40 0.003 0.997 −7.71 ± 0.07
11 4-MeC6H4CH2NHEt 2.38 – 10.04 7.40 0.002 0.998 −6.97 ± 0.08
12 4-MeC6H4CH2NHPr 2.96 130.80 9.98 7.40 0.003 0.997 −6.97 ± 0.03
13 4-MeC6H4CH2NHBu 3.49 82.02 9.98 7.40 0.003 0.997 −6.72 ± 0.04
14 4-MeC6H4CH2NH(CH2)4Me 4.26 22.87 10.08 7.40 0.002 0.998 −6.00 ± 0.07
15 4-MeC6H4CH2NH(CH2)5Me 4.96 16.43 10.17 7.40 0.002 0.998 −5.87 ± 0.02
16 4-MeC6H4CH2NH(CH2)6Me 5.12 6.07 10.02 7.40 0.002 0.998 −5.79 ± 0.03
17 Alprenolol 3.10 – 9.59 7.40 0.006 0.994 −7.10 ± 0.06
18 Propranolol 3.48 – 9.53 7.40 0.007 0.993 −7.90 ± 0.10
aData from Zhang et al.16
bSolubility in units of mg/mL of the compounds in 0.02 M phosphate buffer pH 7.4.
cFn and Fi are the fraction of neutral and ionic species in a given pH.
dValues are the average ± SD, n = 3–6; Kp in units of cm/s.
compound was freshly prepared by diluting the re-
spective saturated solution to a concentration of 80%
of solubility, except for four extremely soluble com-
pounds (#10, 11, 17, and 18 in Table 1), which were
dissolved in 0.02 M phosphate buffer pH 7.4 at a con-
centration of 271.6 mg/mL for #10, 81.2 mg/mL for
#11, 72.2 mg/mL for #17, and 92.9 mg/mL for #18. The
stratum corneum (SC) side of epidermis sheet was
placed upward to the air and the underside supported
by a dialysis membrane (Medicell, London, United
Kingdom) was in contact with the receptor medium.
The Franz cell was moved into an incubator set at
32◦C, with the receptor medium stirred by a mag-
netic bar. After equilibration for 60 min, the Franz
cell was overturned repeatedly up to the removal of all
air bubbles in receptor chamber. Donor solution (0.5
mL) was added into the donor chamber, and then the
opening of the Franz cell was enclosed with Parafilm R©
(Pechiney Plastic Packaging, Chicago, Illinois). The
receptor liquid was sampled by 0.3 mL with a follow-
ing replacement (receptor medium) at fixed times. For
each compound, the skin permeability was measured
in no less than three parallel experiments.
HPLC Analysis
The quantitative analyses of the compounds were
carried out with a System Gold R© HPLC (Beckman
Coulter, Fullerton, California) equipped with an
HPLC pump System-Gold-125 solvent module, a
System-Gold-507e autosampler, and a System-Gold-
UV/VIS-168 detector. The HPLC column used was
a Symmetry R© C18 (4.6 × 100 mm2 internal diame-
ter 3.5:m) from Waters (Milford, Massachusetts).
The isocratic elution method was performed at room
temperature in HPLC measurements. The mobile
phases consisted of 0.02 M phosphate buffer pH 7.0
and methanol in proportions ranging from 80:20 to
20:80. The phosphate buffer was filtered through
a 0.45:m HA Millipore filter (Millipore, Milford,
Massachusetts) under vacuum before being mixed
with methanol. The injection volume was 20:L, and
the flow rate was 1 mL/min. The compounds were de-
tected using the ultraviolet–visible detector at the
maximum absorption wavelength λmax. For each com-
pound, the calibration linear curve was constructed
in a constant concentration range (0.5–100:g/mL),
with a square regression coefficient of 0.999–1.000.
In addition, each sample was injected in triplicate.
Data Treatment
The cumulative amount (Q) of each compound per-
meated through human epidermis was plotted as a
function of time (t). The permeability Kp was calcu-
lated by dividing the steady-state flux (J) that is the
slope for the linear portion of the accumulation curve
by the concentration of the donor solution (C), in ac-
cordance with the following equation:
Kp = JC =
dQ
dt × C (4)
RESULTS AND DISCUSSION
The values of log Kp for some ionizable compounds
(including nine acids and nine bases) across human
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epidermis membrane were measured in this study
(Table 1). A donor solution of high concentration (80%
of the solubility for most compounds) was applied in
in vitro permeation studies in order to achieve an
easy-to-monitor transdermal process. But as a result,
the 0.02 M phosphate buffer pH 7.4 used as the donor
medium failed to control the pH after addition of some
solutes. The actual pH values of donor solutions were
determined prior to permeation experiments (shown
in Table 1). The fraction of neutral and ionic species
(Fn and Fi) were calculated for each compound in the
donor solution and given in Table 1. It can be seen
that some of the acids were partly ionized, instead of
complete ionization as expected. The bases were fully
ionized thanks to the use of the respective hydrochlo-
ride salt. In this work, the “complete ionization” was
defined so that the fraction of ionic species at a given
pH is more than 0.990. Meanwhile, we also used the
experimental log Kp data of the ionic species of five
nonsteroidal anti-inflammatory drugs (NSAIDs) ob-
tained by Singh and Roberts18 (Table 2), considering
the similar experimental conditions and that the re-
ported log Kp values (cm s−1) for naproxen (−6.71) and
indomethacin (−7.22) are, respectively, very close to
our measurement (−6.73) and the value (−7.00) ob-
tained by Hirvonen et al.,19 where the Kp value for
propranolol is −7.87 (in our work, −7.90). It should
be noted that in Ref. 18, the reported value of Kp at
0% ionization for piroxicam is incorrect—it should be
0.34 × 10−2 cm/h, not 3.40 × 10−2 cm/h. This may be
recalculated using the same method by the investiga-
tors, and also seen in their Figure 2.
The experimental log Kp data set for neutral species
previously collected by Abraham and Martins11 were
carefully appraised in terms of whether the given ex-
perimental conditions allowed an exact calculation of
the ionization extent of permeants in the donor solu-
tions. Donor solutions are usually buffered for ioniz-
able compounds, but if the compound concentration is
too high, the buffering capacity may not be enough to
lead to the desired concentrations of ionized or neu-
tral species. Only if the pH of the donor solutions
is determined after the addition of the ionizable com-
pound to the buffer solution can the fraction of neutral
or ionized species be determined accurately. In a num-
ber of cases, we had to omit the data obtained for
ionizable compounds because of an uncertain ionic
fraction. The data for a series of phenolic compounds
whose pKa values are between 8.0 and 10.0 were de-
termined by Roberts et al.20 using distilled water as
the donor medium, so we can estimate that at their
threshold concentrations for skin damage offered by
the workers, the compounds exist almost entirely in
the neutral form. The log Kp data for four phenylene-
diamine hair dyes are also available from Bronaugh
and Congdon,21 who used a borate buffer pH 9.7 to
prevent ionization.
Singh and Roberts18 gave values of Kp for five
NSAIDs, both for the neutral species and for the fully
ionized species, where the ratio of Kp for the neu-
tral form to the ionized anion averages 70 except for
piroxicam where the ratio is 29. However, piroxicam
is a rather unusual compound, and is a “weak” zwit-
terion with a weakly acidic phenolic group (pKa 5.46)
and a weakly basic pyridyl nitrogen (pKa 1.86).22 So,
we can regard the ratio as 70 in general. Then, for
five phenyl fatty acids (#1–5) in Table 1, we can ana-
lyze the observed Kp data for the mixture of neutral
and ionic species, using the neutral–anion ratio of 70
together with Eq. 5 to obtain the “observed” values for
the neutral and the ionic species, as shown in Table 2.
Note that in Table 2, the naproxen anion is included
twice. One is our observed value for the anion and the
other is the value observed by Singh and Roberts.18
We need to include both of these because it is the data
by Singh and Roberts18 on the neutral and ionized
species that help us to obtain the ratio as 70.
Kp = Kp(i) × Fi + Kp(n) × Fn (5)
Abraham and Martins11 left out a number of hy-
drophilic compounds on the grounds that they might
permeate by a different mechanism. We can see no
reason to omit these, and so we include urea, man-
nitol, ouabain, and the tetraethylammonium ion; we
deal with the latter later on, as a test compound to
see if we can predict the Kp value. We were unable to
include sucrose and raffinose because of the difficulty
in assigning descriptors to these two compounds.
Roy and Flynn23 studied the influences of pH on
Kp of fentanyl and sufentanyl, and measured their
Kp as a function of pH. In their work, they used the
value of Kp at pH 2.88 as that of ionic species for both
compounds. At first sight, it seems to be rather rea-
sonable. But we found that the Kp values at pH 2.88
and at pH 5.08 of each compound are quite different,
where the ionic fractions are over 0.999. Furthermore,
for these two compounds, the predictions of Kp at dif-
ferent pH using the Kp values of neutral and ionic
species shown by the investigators in their Table VI
would be much lower than the experimental values at
the pH range from 5.0 to 8.0. Hence, we have to omit
these data in view of data reliability.
In a few cases, large initial lag times were observed,
but all the Kp values that we have used have been ob-
tained from steady-state portions of the permeation—
time plots.
All the compounds and species (compounds #1–85
from Abraham and Martins11; compounds #86–108
from our work; compounds #109–118 from Singh and
Roberts18) used in our analysis are shown in Table 2.
The chemical structures of the hydrocortisone esters,
1a–1k, are given in Figure 1. The Kp values are all
in centimeter per second. We can now apply Eq. 2,
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Table 2. Compounds and Species Used in This Work, Their Solute Descriptors, Experimental Log Kp Values, and Log Kp Values
Calculated from Eq. 6
No. Solute Ea Sa Aa Ba Va J+a J−a Obsb Calcb
1 Water 0.000 0.45 0.82 0.35 0.1673 0.0000 0.0000 −6.28 −6.48
2 Methanol 0.278 0.44 0.43 0.47 0.3082 0.0000 0.0000 −6.38 −6.41
3 Ethanol 0.246 0.42 0.37 0.48 0.4491 0.0000 0.0000 −6.08 −6.12
4 Propan-1-ol 0.236 0.42 0.37 0.48 0.5900 0.0000 0.0000 −5.93 −5.82
5 Butan-1-ol 0.224 0.42 0.37 0.48 0.7309 0.0000 0.0000 −5.70 −5.53
6 Pentan-1-ol 0.219 0.42 0.37 0.48 0.8718 0.0000 0.0000 −5.30 −5.24
7 Hexan-1-ol 0.210 0.42 0.37 0.48 1.0127 0.0000 0.0000 −4.92 −4.95
8 Heptan-1-ol 0.211 0.42 0.37 0.48 1.1536 0.0000 0.0000 −4.57 −4.66
9 Octan-1-ol 0.199 0.42 0.37 0.48 1.2950 0.0000 0.0000 −4.30 −4.36
10 Nonan-1-ol 0.193 0.42 0.37 0.48 1.4354 0.0000 0.0000 −4.30 −4.07
11 Decan-1-ol 0.191 0.42 0.37 0.48 1.5763 0.0000 0.0000 −4.15 −3.78
12 dl-Butan-2,3-diol 0.341 0.93 0.61 0.88 0.7896 0.0000 0.0000 −7.38 −6.81
13 2-Ethoxyethanol 0.237 0.52 0.31 0.81 0.7896 0.0000 0.0000 −6.68 −6.32
14 Phenol 0.805 0.89 0.60 0.30 0.7751 0.0000 0.0000 −5.27 −5.31
15 2-Methylphenol 0.840 0.86 0.52 0.30 0.9160 0.0000 0.0000 −4.88 −4.98
16 3-Methylphenol 0.822 0.88 0.57 0.34 0.9160 0.0000 0.0000 −4.89 −5.11
17 4-Methylphenol 0.820 0.87 0.57 0.31 0.9160 0.0000 0.0000 −4.83 −5.03
18 3,4-Dimethylphenol 0.830 0.86 0.56 0.39 1.0569 0.0000 0.0000 −4.52 −4.94
19 4-Ethylphenol 0.800 0.90 0.55 0.36 1.0569 0.0000 0.0000 −4.53 −4.87
20 2-Isopropyl-5-methylphenol 0.822 0.79 0.52 0.44 1.3387 0.0000 0.0000 −4.35 −4.45
21 2-Chlorophenol 0.853 0.88 0.32 0.31 0.8975 0.0000 0.0000 −4.56 −4.99
22 4-Chlorophenol 0.915 1.08 0.67 0.20 0.8975 0.0000 0.0000 −4.52 −4.91
23 4-Bromophenol 1.080 1.17 0.67 0.20 0.9501 0.0000 0.0000 −4.52 −4.86
24 4-Chloro-3-methylphenol 0.920 1.02 0.67 0.22 1.0384 0.0000 0.0000 −4.34 −4.64
25 4-Chloro-3,5-dimethylphenol 0.925 0.96 0.64 0.21 1.1793 0.0000 0.0000 −4.31 −4.29
26 Resorcinol 0.980 1.11 1.09 0.52 0.8338 0.0000 0.0000 −6.70 −6.05
27 2-Naphthol 1.520 1.08 0.61 0.40 1.1441 0.0000 0.0000 −4.65 −4.98
28 Benzyl alcohol 0.803 0.87 0.39 0.56 0.9160 0.0000 0.0000 −5.30 −5.64
29 4-Hydroxybenzyl alcohol 0.998 1.20 0.86 0.81 0.9747 0.0000 0.0000 −6.26 −6.51
30 2-Phenylethanol 0.811 0.86 0.31 0.65 1.0569 0.0000 0.0000 −5.20 −5.56
31 5,5-Diethylbarbituric acid 1.030 1.14 0.47 1.18 1.3739 0.0000 0.0000 −7.29 −6.52
32 5-Ethyl-5-butylbarbituric acid 1.030 1.14 0.47 1.18 1.6557 0.0000 0.0000 −7.05 −5.94
33 Aniline 0.955 0.96 0.26 0.41 0.8162 0.0000 0.0000 −4.73 −5.45
34 Benzaldehyde 0.820 1.00 0.00 0.39 0.8730 0.0000 0.0000 −3.93 −5.20
35 Benzene 0.610 0.52 0.00 0.14 0.7164 0.0000 0.0000 −4.27 −4.62
36 Butanone 0.166 0.70 0.00 0.51 0.6879 0.0000 0.0000 −5.42 −5.70
37 Caffeine 1.500 1.82 0.08 1.25 1.3632 0.0000 0.0000 −7.08 −6.97
38 Diethylcarbamazine 0.645 1.30 0.00 1.55 1.7241 0.0000 0.0000 −6.15 −6.67
39 Diethylether 0.041 0.25 0.00 0.45 0.7309 0.0000 0.0000 −5.37 −5.23
40 Digitoxin 3.460 5.63 1.33 4.35 5.6938 0.0000 0.0000 −8.15 −8.68
41 Urea 0.501 1.49 0.83 0.84 0.4646 0.0000 0.0000 −7.93 −7.71
42 Mannitol 0.836 2.33 0.87 1.77 1.3062 0.0000 0.0000 −8.42 −8.90
43 Ouabain 4.000 6.50 0.90 3.56 4.1615 0.0000 0.0000 −9.66 −10.04
44 Ethylbenzene 0.613 0.51 0.00 0.15 0.9982 0.0000 0.0000 −3.00 −4.06
45 5-Ethyl-5-(3-methylbutyl)barbital 1.030 1.11 0.47 1.23 1.7966 0.0000 0.0000 −5.98 −5.77
46 5-Ethyl-5-phenylbarbital 1.630 1.80 0.73 1.15 1.6999 0.0000 0.0000 −6.68 −6.22
47 Fluocinonide 1.950 2.48 0.31 2.51 3.4603 0.0000 0.0000 −6.33 −6.43
48 5-Fluorouracil 0.720 0.84 0.57 1.02 0.7693 0.0000 0.0000 −6.82 −7.21
49 Glycerol trinitrate 0.586 2.11 0.00 0.35 1.2300 0.0000 0.0000 −5.21 −4.84
50 4-Hydroxy-methylphenylacetate 0.908 1.46 0.59 0.68 1.2722 0.0000 0.0000 −5.26 −5.57
51 4-Hydroxyphenylacetamide 1.280 2.03 0.86 0.94 1.1724 0.0000 0.0000 −6.89 −6.86
52 Isoquinoline 1.211 1.00 0.00 0.54 1.0443 0.0000 0.0000 −5.11 −5.29
53 8-Methoxypsoralen 1.611 1.70 0.00 0.80 1.4504 0.0000 0.0000 −5.12 −5.51
54 Methyl 4-hydroxybenzoate 0.900 1.37 0.69 0.45 1.1313 0.0000 0.0000 −5.12 −5.23
55 Methylphenylether 0.708 0.75 0.00 0.29 0.9160 0.0000 0.0000 −4.68 −4.72
56 Toluene 0.601 0.52 0.00 0.14 0.8573 0.0000 0.0000 −3.64 −4.32
57 4-Chloro-m-phenylenediamine 1.358 1.50 0.23 0.69 1.0384 0.0000 0.0000 −6.54 −6.02
58 o-Phenylenediamine 1.260 1.40 0.24 0.73 0.9160 0.0000 0.0000 −6.70 −6.33
59 p-Phenylenediamine 1.300 1.73 0.31 0.84 0.9160 0.0000 0.0000 −6.98 −6.80
60 Aldosterone 2.010 3.47 0.40 1.90 2.6890 0.0000 0.0000 −7.45 −6.88
61 Corticosterone 1.860 3.43 0.40 1.63 2.7389 0.0000 0.0000 −6.84 −6.02
62 Dexamethasone 2.040 3.51 0.71 1.92 2.9132 0.0000 0.0000 −7.27 −6.59
(Continued)
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Table 2. Continued
No. Solute Ea Sa Aa Ba Va J+a J−a Obsb Calcb
   63         Estradiol                                                           1.800       1.77       0.86        1.10       2.1988        0.0000       0.0000 −5.61 −5.10
64 Hydrocortisone 2.030 3.49 0.71 1.90 2.7976 0.0000 0.0000 −7.22 −6.77
65 Progesterone 1.450 3.29 0.00 1.14 2.6215 0.0000 0.0000 −4.90 −4.71
66 Testosterone 1.540 2.59 0.32 1.19 2.3827 0.0000 0.0000 −5.54 −5.13
67 Benzyl nicotinate 1.262 1.60 0.00 0.80 1.6393 0.0000 0.0000 −4.87 −5.04
68 Butyl nicotinate 0.658 1.07 0.00 0.73 1.4542 0.0000 0.0000 −4.86 −4.93
69 Ethyl nicotinate 0.667 1.10 0.00 0.73 1.1724 0.0000 0.0000 −5.28 −5.53
70 Hexyl nicotinate 0.628 1.07 0.00 0.73 1.7360 0.0000 0.0000 −4.83 −4.34
71 2-Hydroxypropyl nicotinate 0.840 1.38 0.35 1.19 1.3720 0.0000 0.0000 −7.55 −6.61
72 Methyl nicotinate 0.710 1.13 0.00 0.71 1.0315 0.0000 0.0000 −5.77 −5.78
73 Methyltriglycol nicotinate 0.730 1.42 0.00 1.79 2.0530 0.0000 0.0000 −6.83 −6.70
74 Triglycol nicotinate 0.950 1.58 0.37 1.78 1.9121 0.0000 0.0000 −8.08 −7.18
75 1a 2.310 3.32 1.01 2.84 3.4924 0.0000 0.0000 −8.14 −7.90
76 1b 2.210 3.77 0.46 2.86 3.7742 0.0000 0.0000 −7.73 −7.39
77 1c 1.990 3.11 0.46 2.61 3.5922 0.0000 0.0000 −7.23 −6.77
78 1d 2.100 3.15 1.06 2.61 3.4513 0.0000 0.0000 −6.69 −7.28
79 1e 2.020 3.58 1.06 2.61 3.8740 0.0000 0.0000 −6.24 −6.60
80 1f 2.210 4.15 0.96 2.78 3.9151 0.0000 0.0000 −6.13 −7.22
81 1g 2.020 3.49 0.83 2.64 3.7174 0.0000 0.0000 −6.12 −6.89
82 1h 1.870 2.90 0.46 2.16 3.2360 0.0000 0.0000 −6.02 −6.19
83 1i 1.930 3.49 0.46 2.61 4.0149 0.0000 0.0000 −5.82 −6.06
84 1j 1.810 3.02 0.46 2.16 3.6587 0.0000 0.0000 −5.30 −5.37
85 1k 1.770 3.05 0.46 2.16 3.9405 0.0000 0.0000 −4.76 −4.79
86 4-MeC6H4CH2NHMe, cation 0.650 2.58 1.42 0.00 1.2604 1.2835 0.0000 −7.71 −7.01
87 4-MeC6H4CH2NHEt, cation 0.640 2.66 1.44 0.00 1.4013 1.2994 0.0000 −6.97 −6.79
88 4-MeC6H4CH2NHPr, cation 0.630 2.63 1.37 0.00 1.5422 1.3290 0.0000 −6.97 −6.52
89 4-MeC6H4CH2NHBu, cation 0.620 2.62 1.34 0.00 1.6831 1.3349 0.0000 −6.72 −6.23
90 4-MeC6H4CH2NH(CH2)4Me, cation 0.610 2.60 1.34 0.00 1.8240 1.3136 0.0000 −6.00 −5.88
91 4-MeC6H4CH2NH(CH2)5Me, cation 0.600 2.60 1.36 0.00 1.9649 1.2956 0.0000 −5.87 −5.56
92 4-MeC6H4CH2NH(CH2)6Me, cation 0.590 2.63 1.36 0.00 2.1058 1.2969 0.0000 −5.70 −5.29
93 Alprenolol, cation 1.100 4.46 1.78 0.00 2.1802 2.2574 0.0000 −7.10 −8.02
94 Propranolol, cation 1.690 4.31 2.07 0.00 2.1695 2.4319 0.0000 −7.90 −8.47
95 Flurbiprofen anion 1.590 4.56 0.07 3.36 1.8174 0.0000 2.5383 −6.20 −6.47
96 Ibuprofen, anion 0.880 3.50 0.08 3.31 1.7556 0.0000 2.4188 −6.03 −6.22
97 Ketoprofen, anion 1.800 5.49 0.01 3.39 1.9564 0.0000 2.4851 −5.71 −6.83
98 Naproxen, anion 1.660 5.07 0.02 3.11 1.7606 0.0000 2.4260 −6.73 −6.43
99 C6H5COOH, anion 0.880 3.05 0.02 2.75 0.9102 0.0000 2.1385 −6.96 −6.95
100 C6H5COOH 0.730 0.90 0.59 0.40 0.9317 0.0000 0.0000 −5.11 −5.25
101 C6H5(CH2)2COOH, anion 0.900 3.43 0.03 3.02 1.1920 0.0000 2.1879 −6.98 −7.15
102 C6H5(CH2)2COOH 0.750 1.18 0.60 0.60 1.2135 0.0000 0.0000 −5.13 −5.33
103 C6H5(CH2)3COOH, anion 0.910 3.59 0.04 3.01 1.3329 0.0000 2.2184 −6.90 −6.83
104 C6H5(CH2)3COOH 0.760 1.29 0.61 0.57 1.3544 0.0000 0.0000 −5.05 −5.02
105 C6H5(CH2)4COOH, anion 0.920 3.63 0.04 3.10 1.4718 0.0000 2.2794 −6.35 −6.65
106 C6H5(CH2)4COOH 0.770 1.24 0.57 0.60 1.4933 0.0000 0.0000 −4.50 −4.77
107 C6H5(CH2)7COOH, anion 0.940 3.87 0.07 3.26 1.8965 0.0000 2.4256 −5.91 −5.95
108 C6H5(CH2)7COOH 0.790 1.27 0.57 0.62 1.7771 0.0000 0.0000 −4.06 −4.26
109 Salicylic acid, anionc 1.050 3.19 0.08 2.74 0.9689 0.0000 2.2641 −7.04 −6.59
110 Indomethacin, anionc 2.390 5.62 0.10 4.38 2.5084 0.0000 2.9899 −7.22 −7.21
111 Diclofenac, anionc 1.960 5.31 0.03 3.35 2.0035 0.0000 2.6243 −7.00 −6.21
112 Naproxen, anionc 1.660 5.07 0.02 3.11 1.7606 0.0000 2.4261 −6.71 −6.43
113 Piroxicam, anionc 2.710 6.81 0.00 3.78 2.2285 0.0000 2.7356 −7.50 −7.37
114 Salicylic acidc 0.900 0.85 0.73 0.37 0.9904 0.0000 0.0000 −5.07 −5.08
115 Indomethacinc 2.240 1.47 0.58 1.43 2.5299 0.0000 0.0000 −5.39 −5.12
116 Diclofenacc 1.810 1.85 0.55 0.77 2.0250 0.0000 0.0000 −5.30 −4.51
117 Naproxenc 1.510 2.02 0.60 0.67 1.7821 0.0000 0.0000 −4.97 −4.81
118 Piroxicamc 2.560 2.71 0.00 1.21 2.2500 0.0000 0.0000 −6.02 −5.52
aValues of solute descriptors can be calculated or estimated as detailed in Ref. 14.
bKp in units of cm/s.
cMeasured by Singh and Roberts18; piroxicam (pKa = 5.46) is slightly less than 99% ionized at pH 7.4, so we made a minor correction to the reported value
(#113) using Eq. 5 to subtract the contribution of neutral piroxicam.
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Figure 1. Chemical structures of the hydrocortisone es-
ters, 1a–1k.
where SP = log Kp, to all 118 compounds or species,
using the multiple linear regression analysis of log
Kp against the seven solute descriptors. The obtained
LFER model is as follows:
log Kp
= −5.420(±0.211) − 0.102(±0.296)E − 0.457(±0.231)S
−0.324(±0.337)A − 2.680(±0.300)B + 2.066(±0.249)V
−1.938(±0.485)J+ + 2.548(±0.337)J−
N = 118, R2 = 0.861, SD = 0.462, F = 97.3 (6)
Here, 95% confidence limits are given in parenthe-
ses; N is the number of compounds or species studied;
R is the correlation coefficient; SD is the standard
deviation, and F is the Fisher F-statistic.
In the construction of Eq. 6, we had to make the ap-
proximations that a neutral–anion ratio of 70 applied
to the five acids (#1–5) in Table 1 and that for the re-
maining 13 compounds in Table 1, we could ignore the
contribution from the neutral form altogether. Now
that we have an equation for log Kp, we can use it
to calculate the contribution of the ionic and neutral
forms for all 18 compounds. For the five acids (#1–5),
and for all 10 acids, the new ratio was found to be 61,
so that our assumption of a ratio of 70 is valid. In the
case of the nine bases (#10–18, Table 1), we can now
calculate the value of log Kp for the neutral species
from Eq. 6 and the descriptors for the neutral species
and deduce that, indeed, the neutral species make a
negligible contribution to log Kp. We point out that we
have also constructed an equation for log Kp taking a
neutral–anion ratio of 100 for the five acids (#1–5) in
Table 1 and obtain an equation identical to Eq. 6. The
latter, therefore, does not depend on the exact value
of the ratio at all.
Equation 6 is quite comparable to Eq. 3 obtained
only for neutral species with the coefficients in the two
equations reasonably close; the SD value in Eq. 6 is
0.462, which is almost the same as that that for Eq. 3
(0.469). A plot of observed values of log Kp versus cal-
culated values of log Kp on Eq. 6 is shown in Figure 2.
The data points for the anions and cations scatter
randomly over the line of unit slope.
The five neutral phenyl fatty acids and their cor-
responding anions (#99–108 in Table 2) fit Eq. 6 very
well; the average absolute residual is only 0.202 log
units. For all 10 acids, the ratio of neutral to ionic
Kp values is 61.The same analysis was applied to the
bases in Table 2. For the seven N-alkylbenzylamines,
the ratio is 57, but for alprenolol and propranolol,
the ratios are much larger at 340 and 975, respec-
tively. Our view is that neutral acids and bases per-
meate across the epidermis very much faster than
the corresponding ionized species, but that the ac-
tual ratio depends on their structures. Kasting and
Bowman24 have determined the passive permeation
of the sodium ion across human skin as 4.6 × 10−7
cm/min, which corresponds to log Kp = −8.12 with
Kp in units of cm/s. Abraham and Acree13 have ob-
tained descriptors for the sodium ion, and if these are
combined with the coefficients of Eq. 6, we predict
log Kp = −7.41, in good agreement with the exper-
imental value. A value of −7.84 for log Kp for pas-
sive permeation of the tetraethylammonium ion can
be obtained from a graph given by Peck et al.25 Our
predicted value is −6.48 in fair agreement with ex-
periment. This is the first time that permeation of
an ion across a membrane has been predicted just
from the physicochemical properties of the ion and
membrane.
The system coefficients j+ and j− in Eq. 6 show
that the additional ion–skin interaction plays an im-
portant role in ionic permeation process. However, it
should be noted that skin permeation of ionic species
is influenced by all the terms in Eq. 6 and not just by
the terms in J+ and J−.
The predictive standard deviation (PSD) obtained
from the leave-one-out statistics is a useful estimate
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Figure 2. A plot of calculated values of log Kp on Eq. 6 versus the observed values of log Kp.,
neutral species; , anions from carboxylic acids; , cations (protonated bases).
of the predictive power of the regression models,
especially for our case that includes data for ionic
species.26,27 The PSD value for Eq. 6 is 0.502, which
is possibly close to what can be achieved without over-
fitting. It is difficult to predict log Kp to less than 0.5
log unit for large and varied data sets as discussed
previously.11 Moreover, the data set we used includes
both neutral species and ionic species.
It is of interest to investigate the connection
between the human skin permeation process and
water–organic solvent or water–artificial membrane
partitions (Table 3) by comparison of the seven system
coefficients (e, s, a, b, v, j+, and j−). It is one of our aims
to build a physicochemical model based on lipophilic-
ity indices from biomimic partitioning systems for
predicting Kp. Note that in Table 3, the retention fac-
tors kcer in cerasome electrokinetic chromatography
(EKC), measured by Zhang et al.,16 are proportional
to partition coefficients between water and cerasome
(made of skin lipids), as cerasome EKC is actually the
water–cerasome partition system based on capillary
electrophoresis.
In order to compare a reasonable number of sys-
tems simultaneously, we use the analysis method of
Abraham and Martins,11 where the coefficients are
regarded as points in seven-dimensional space. The
Table 3. Coefficients in General LFER Equations for Human Skin Permeation and a Series of Water–Solvent/Artificial Membrane
Partitions; d′ Values Compared with Skin Permeation (Neutral Molecules and Ions) and to Skin Partition (Neutral Molecules)
d′
Solvent/Membrane c e s a b v j+ j− Perma Parta
Methanol 0.276 0.334 −0.714 0.243 −3.320 3.549 −2.609 3.027 1.97 2.13
Ethanol 0.222 0.471 −1.035 0.326 −3.596 3.857 −3.170 3.085 2.63 2.62
1-Propanol 0.139 0.405 −1.029 0.247 −3.767 3.986 −3.077 2.834 2.68 2.80
1-Butanol 0.152 0.438 −1.177 0.096 −3.919 4.122 −3.605 2.685 3.09 3.03
1-Hexanol 0.115 0.492 −1.164 0.054 −3.971 4.131 −3.100 2.940 2.90 3.06
Propanone 0.313 0.312 −0.121 −0.608 −4.753 3.942 −2.288 0.078 3.80 3.37
Acetonitrile 0.413 0.077 0.326 −1.566 −4.391 3.364 −2.243 0.101 3.59 3.15
NMP 0.147 0.532 0.275 0.840 −4.794 3.674 −1.797 0.105 3.92 3.34
DMSO −0.194 0.327 0.791 1.260 −4.540 3.361 −3.387 0.132 4.16 3.24
EG −0.270 0.578 −0.511 0.715 −2.619 2.729 −1.300 2.363 1.56 1.29
PC 0.004 0.168 0.504 −1.283 −4.407 3.421 −1.989 0.341 3.41 3.09
Wet 1-octanol, log Poct 0.088 0.562 −1.054 0.034 −3.460 3.814 −3.023 2.580 2.40 2.50
Cerasome, log kcerb −1.922 0.200 −0.629 −0.109 −1.451 1.757 0.334 1.958 2.70 0.86
Water–skin partition 0.341 0.341 −0.206 −0.024 −2.178 1.850 0.000 0.000 0.80c 0.00
Skin permeation, log Kp −5.420 −0.103 −0.457 −0.324 −2.680 2.066 −1.939 2.548 0.00 0.80
aReference system; “perm” means skin permeation and “part” means water–skin partition.
bRetention factors in cerasome EKC in log units.
cFor neutral compounds only, j+ = j− = 0.
NMP, N-methylpyrrolidinone; DMSO, dimethyl sulfoxide; EG, ethylene glycol; PC, propylene carbonate.
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distance between the points, d′, calculated by simple
trigonometry, is then a measure of how close are the
sets of coefficients. As the coefficients have specific
chemical meanings, the smaller the value of d′, the
closer are the coefficients in a chemical sense and the
closer are the systems in a chemical sense. Abraham
and Martins11 suggested that for a system to be a
good chemical model, d′ should be less than around
0.5–0.8 units. Values of d′ with skin permeation as
the reference system are shown in Table 3.
From Table 3, we find that skin permeation is not
closely related chemically to any of the partitioning
systems for which an ionic equation is available, not
even to the water–cerasome system. Abraham and
Martins11 have obtained an equation for water–skin
partition, log Ksc, but for neutral solutes only. How-
ever, we can calculate d′ with water–skin partition
as the standard system, although for neutral solutes
only (Table 3). Now cerasome (d′ = 0.86) is a reason-
able model. Methanol (d′ = 2.13), and ethylene glycol
(d′ = 1.29) also  have  low  values  of d′—lower than
for partition into aprotic solvents or less polar sol-
vents—which suggests that neutral compounds par-
tition into rather polar parts of skin.
We can consider skin permeation in terms of parti-
tion from water into skin followed by diffusion across
the under layer of skin, as described by Eq. 7,
log Kp = log Ksc + log Dsch (7)
in which Dsc is the diffusion coefficient in the SC of
thickness h. Log Ksc has been supposed to correlate
with log Poct for neutral species,28 and the latter to be
related to the water–liposome partition coefficient log
Klw.29 However, it is known that log Poct is not a very
good model for water–skin partition, with d′ as 2.08
units (Table 3), and so we analyze Eq. 7 without use
of the log Poct model. Several authors have suggested
that there are two parallel pathways through the SC,
for example, Wang et al.30 wrote (in their nomencla-
ture) Eq. 8 as follows:
Psc/w = (Psc/w)comp + (Psc/w)polar (8)
However, it is not possible to dissect log Kp into
two constituent terms just through an equation such
as Eq. 8. To make any progress through Eq. 8, Wang
et al.30 had to calculate the first term from a set of
physicochemical parameters.
It would be very interesting if we had data on par-
titioning into skin by anions and cations because we
could then dissect ionic effects on permeation into
partition and diffusion and so determine structural
effects on the diffusion of ionic species. In the absence
of actual log Ksc data, we can use partition into cera-
Table 4. Retarding Factors for Permeation of Ionic Species
Through Skin by Comparison to the Corresponding Neutral
Compounds; Comparison with Permeation through the
Blood-Brain Barrier
Retarding Factors
Species N Diffusiona Partition Total
Skin Permeation
Neutral compounds 95 0 0.0 0
Acid anions 14 13 4.7 61
Base cations 7 82 0.66 54
Alprenolol cationb 1 1200 0.28 340
Propranolol cationb 1 5250 0.18 955
Water–Brain Permeation
Neutral compounds 24 0.0 0.0 0
Acid anions 3 6.9 15.0 105
Base cations 21 5.9 2.2 13
aDiffusion in skin and in the blood–brain barrier.
bDiffusion and partition values calculated with reference to the neutral
alprenolol and propranolol bases.
some, Eq. 9,16
log kcer = −1.922 + 0.200E − 0.629S− 0.109A
−1.451B + 1.757V + 0.334J+ + 1.958J− (9)
as an estimate of partitioning into skin and then ob-
tain relative values of log Dsc, Eq. 10, by subtraction
of Eq. 9 from Eq. 6. The constant term in Eq. 10 is
unknown, but in the present context is irrelevant.
logDsc (est) = c − 0.302E + 0.172S− 0.215A
−1.229B + 0.309V − 2.272J+ + 0.590J− (10)
From Eqs. 6, 9, and 10, we can then deduce the ef-
fect of ionization, by comparison with neutral solutes,
on the overall permeation and the separate partition
and diffusion process. This is given in Table 4 in terms
of the retarding factors for the ionized solutes. The
retarding factor is the effect of an ionic species in re-
ducing the rate of permeation by comparison to the
corresponding neutral species.
The poor permeability of anions is partly due to
poor partition into the SC but mostly due to slow dif-
fusion of the ionized species (by comparison to the
corresponding neutral species). For cations, poor per-
meability is entirely due to very slow diffusion (again
by comparison to the neutral species). This is quite
different to diffusion in water, where ionic species dif-
fuse at about the same rate as the corresponding neu-
tral compounds, see Eq. 11.31
log D (inwater) = 0.31 − 0.027A − 0.360V
+0.096J+ − 0.004J− (11)
A possible explanation for ionic slow diffusion is
as follows: The ionized forms definitely bind closer
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to the bilayer interface than the neutral form. The
solute moves in the lipid bilayers with preference to-
ward lateral diffusion regardless of the solute size
and location. The highly ordered lipid chains near
the bilayer interface result in the steric resistance of
solutes.32,33 As a result, the ionic species encounters
a larger retarding effect to their movement.
The only other permeation process for which data
on neutral molecules and ions has been examined
is permeation from saline through the blood–brain
barrier,14 see Eq. 12.
log PS(blood− brain barrier)
= −1.268 − 0.047E − 0.876S− 0.719A − 1.571B
+1.767V + 0.469J+ + 1.663J− (12)
Abraham14 suggested that water–ethanol mix-
tures, such as 40% ethanol (v/v), were reasonable
models for partition into polar areas of the blood–
brain barrier, but this was for neutral molecules only.
Since then, Abraham and Acree34 have obtained equa-
tions for the partition of both neutral molecules and
ions, so that we can now use such an equation, Eq. 13,
as a model for partition into the blood–brain barrier.
Then, as before, an equation for diffusion, Eq. 14, can
be obtained by subtraction of coefficients.
log P(water − 40% ethanol)
= −0.221 + 0.131E − 0.159S+ 0.171A
−1.809B + 1.918V − 1.271J+ + 1.676J− (13)
log D (blood− brainbarrier)
= c − 0.178E − 0.717S− 0.890A + 0.238B
−0.151V + 1.740J+ − 0.013J− (14)
The effect of ionization can now be dissected into
partition and diffusion, as before, again with respect
to neutral molecules as shown in Table 4. Compar-
ison of the two sets of data shows that base cations
are particularly retarded on diffusion through the SC.
We suggest that diffusion of the base cations is made
difficult by the presence of negatively charged groups
in the SC. It is known that the intercellular lipid mul-
tilayers in the SC, consisting mainly of ceramides,
cholesterol, and fatty acids, are the main pathway
for most molecules. The ionizable fatty acids impart a
negative charge to the intercellular pathway.35 Hence,
when the cations diffuse in highly ordered lipid layers,
their movement is retarded under the electrostatic at-
traction of negatively charged head groups in lipids.
CONCLUSION
It has been possible to extend the LFER model for
human skin permeation of neutral solutes, Eq. 3, to
include the permeation of anions and cations. From
our experimental Kp for ionic species, one extra term
(j+J+) was obtained for cations and another extra
term (j−J−) was obtained for anions, leading to Eq. 6.
The PSD of this equation is 0.502, which is quite good
for a set of 118 compounds including neutral species
and ionic species. Neutral acids and bases permeate
through human skin faster than their corresponding
ionic species, but the ratio of neutral to ionic per-
meation depends on the actual structures. The skin
permeation process cannot be mimicked perfectly by
water–phase/artificial membrane partitions, as the
latter contains no physicochemical information on lat-
eral diffusion in the SC. The poor permeation of ionic
species is mainly due to their slow diffusion across
the SC, especially for a number of base cations.
Equation 6 indicates that an increase in volume
of a solute by itself will lead to an increase in log
Kp. This is in line with a number of equations that
correlate log Kp with log Poct for neutral species, and
which yield a positive coefficient for the independent
variable log Poct. For example, Buchwald and Bodor36
give the following equation for 98 compounds,
log Kp(cm/s) = −6.93 + 0.46 log Poct (15)
The relationship between log Poct and volume is
well known and for 613 compounds is given by
Eq. 16,37
log Poct = 0.088 + 0.562E − 1.054S+ 0.034A
−3.460B + 3.814V (16)
As log Kp depends positively on log Poct, and be-
cause log Poct depends positively on volume, it is en-
tirely consistent to find that log Kp depends positively
on volume.
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Table 1. Current techniques for analyzing the lipids-water partitions and their respective characters 
Techniques Advantages Disadvantages Others 








Relatively higher speed; 
log Plip values for both ionic 
and neutral speciesa 








small sample amount; 
low purity requirement 
Lipid monolayer with lack of 
lateral mobility of lipids and 
density of phospholipid 
head-groups  






small sample amount; 
low purity requirement 
Unstable; irreproducible 
column preparation; 
unsuitable for lipophilic 
solutes (long retention times 
for many neutral molecules) 




small sample amount; 
low purity requirement 
Unsuitable for neutral 
solutes with neutral 
liposomes used 
Set up on capillary 
electrophoresis (CE) 
a log Plip represents the partition coefficient between liposome and water. 
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4. Discussion  
LFER is a quite useful tool, not only to reveal the physicochemical nature of equilibrium systems 
but also to predict the corresponding equilibrium coefficients. In this study, LFER serves as the 
core analytical method, as being used to compare different partitioning systems by comparison of 
system coefficients, which can be used to characterize the given systems, and to predict log Kp of 
both neutral and ionic species. In line with the aims of this study, I will discuss here: comparison 
of partitioning systems (centered around the SC-water partition), LFER analysis for skin perme-
ability of both neutral and ionic species, and application of the Potts-Guy model on ionic species. 
4.1 Comparison of Partitioning Systems  
In Publication 1 and Publication 3, the compounds with a broad structural diversity were selected 
and their retention factors were measured in LEKC, where cerasome and liposome (POPC80/PS20) 
were used as the investigated liposomes, respectively. The retention factor in LEKC serves as a 
partition index since it is proportional to the corresponding partition coefficient, as is the case for 
lipophilicity indices in ILC and IAM chromatography.  
      Abraham and Acree (2010a, b, c, d) have obtained solute descriptors for many anions derived 
from acids by deprotonation and for many cations derived from bases by addition of a proton. In 
cases where the descriptors were not determined, we used the equations set out by Abraham and 
Acree (2010a) for the calculation of descriptors. Once the descriptors for the relevant species are 
available, the dependent variable, in this case the retention factors, can be regressed against them 
for the LFER equation on the lines of Eq. 1.9, see Publication 1 and Publication 3. 
       In order to better compare liposomes with organic solvents, which are electrically neutral, on 
solute interaction, it is very necessary to make use of neutral liposome. Given that there has been 




neutral species, which are required for LFER analysis, a neutral IAM from Liu et al. (2008) was 
used as a substitute for neutral liposome. In addition, it was investigated what the crucial differ-
ence is between immobilized lipid monolayers in IAM and lipid bilayers in liposomes in parti-
tion processes. Liu et al. (2008) have recently measured a diversity of neutral and ionized com-
pounds on an IAM.PC.DD2 column, where phosphatidylcholines (PC) were bound to gel beads. 
Eq. 1.9 was also applied to the capacity factors obtained in this IAM system, see Publication 3. 
Using the LFER equations obtained above, we carried out the following comparisons of much 
interest. 
4.1.1 Comparison Methods of LEER Coefficients 
A quantitative method for comparison of coefficients is to consider the seven coefficients of any 
system (that is, e, s, a, b, v, j+ and j-) as a point in seven-dimensional space. The distance between 
the points, d’, calculated by straightforward trigonometry, is then a measure of how close are the 
sets of coefficients. As the coefficients have specific chemical meanings, the smaller the value of 
d’, the closer are the coefficients in a chemical sense and the closer are the systems in a chemical 
sense. Abraham and Martins (2004) suggested that for a system to be a good model, d’ should be 
less than around 0.5-0.8 units.  
       Another useful way to compare the coefficients in a set of equations is to perform a principal 
component analysis (PCA). The seven coefficients are converted into seven linearly uncorrelated 
principal components (PCs) via an orthogonal transformation, which contain exactly the same 
information. The first two principal components (PC1 and PC2) can generally account for most 
of the entire information. A plot of the scores of PC1 against PC2 reveals how ‘close’ the equa-
tions are in terms of chemical interactions.  
       These two methods have their respective focuses, and were employed in this study as needed. 




these relationships.  In contrast, the latter shows full characterization of the relationships among 
all the systems but cannot exactly give the correlation extent of two systems. 
4.1.2 Comparison of Lipid Membrane-Water Systems with Organic Solvent-Water Systems 
In Publication 1 and Publication 3, lipid membrane-water partitions were compared with organic 
solvent-water partitions using LFER equations for ionic species. The results show lipid mem-
branes (including neutral IAM) exhibit a considerably different chemical environment from 
those of organic solvents. Furthermore, partitions into the more polar hydroxylic solvents are 
chemically closer to partitions into lipid membranes as compared to partitions into the less polar 
hydroxylic solvents and into aprotic solvents. Abraham and Acree (2012) have recently obtained 
similar results for neutral species, so that we can now suggest that both neutral and ionic species 
partition into the polar parts of lipid membrane. However on the whole, there is no ‘ideal’ sol-
vent that can be used as a general model for lipid membranes.  
       Additionally, we compared partition into IAM with partition into liposomes in Publication 3. 
Lipid monolayers in IAM are known to differ from lipid bilayers in liposomes in terms of lateral 
mobility of lipids and density of the polar phospholipid head-groups (Ong et al., 1996; Rand and 
Parsegian, 1989). However, it was found that such structural differences just bring about a negli-
gible change on partition properties. Therefore, neutral IAM may be a good surrogate for neutral 
liposome in partition processes. 
4.1.3 Uniqueness of Cerasome on Modeling the Stratum Corneum in Partitions 
The SC-water partition was compared with cerasome-water and organic solvent-water partitions 
in Publication 2, although for neutral species only. However, it can be seen that cerasome is a 
reasonable model for the SC in partitions, with a much lower d’ value (0.86) than those for or-
ganic solvents, and phospholipid liposomes (containing cholesterol or not) whose values have 




tion to skin permeation than other lipid membrane-water partitions and microsomal binding, see 
Publication 3. Hence, cerasome is a unique liposome whose roles on modeling the SC cannot be 
replaced by regular phospholipid liposomes. This is probably due to the unusual structures of 
ceramides, the major type of lipids in the SC. Ceramides consist of derivatives of sphingosine 
bases linked to a variety of fatty acids via amide bonds. Clearly, the polar head-groups in 
ceramides serve as both acceptors and donors of hydrogen bonds by the hydroxyl and amino 
groups as compared to those in phospholipids, which act only as acceptors of hydrogen bonds 
(Moore et al., 1997). Ceramides therefore should give rise to strong hydrogen bonding with so-
lutes that are hydrogen bond bases. Besides, the aliphatic chains in ceramides are mostly long-
chain and saturated, and hence lead to high phase transition temperatures. Ceramides are thus 
mostly in a solid crystalline or gel state at physiological temperature, which exhibits lower parti-
tion coefficients than the state of liquid crystalline membranes (Bano, 2000; Sarmento et al., 
1993). 
4.1.4 Correlation between Skin Permeation and Partitioning Systems 
It was found that skin permeation is not closely related chemically to any of the organic solvent-
water partitions, not even to the cerasome-water partition, see Publication 2. However, this is not 
unexpected. Skin permeation can be considered in terms of partition from water into skin fol-
lowed by diffusion across the under layer of skin. Here, these partitioning systems maybe pro-
vide an estimate for the skin-water partition, but could not contain information on diffusion 
through skin. It was suggested that for neutral species, transport within the SC owns a strong size 
dependence for small solutes (< 300 Da) and a weak size dependence for larger solutes (Johnson 
et al., 1996; Johnson et al., 1997; Mitragotri, 2000). Further, the results of this study suggest that 
the diffusion process for ionic species is more complicated than that for neutral species (see Sec-




It is thus clear that only partitioning system (even the skin-water partition) fails to account for the 
main variance of skin permeation. 
4.2 LFER Analysis for Skin Permeability of Both Species 
The values of log Kp for 18 ionizable compounds (including 9 acids and 9 bases) through human 
epidermis were measured using Franz diffusion cells in Publication 2. After combining these data 
with the experimental log Kp database for neutral molecules compiled by Abraham and Martins 
(2004) and reliable log Kp data for ionic species in literature, the MLR analysis of log Kp against 
the seven solute descriptors yields a LFER equation for skin permeation of both neutral and ionic 
species, with R2 = 0.861 and SD = 0.462 log units. Here and elsewhere, R2 is the squared correla-
tion coefficient and SD is the standard deviation. 
4.2.1 Assessment of Predictive Power 
This equation was found to be quite comparable to the Abraham-Martins model, Eq. 1.10, which 
involves neutral molecules only, with the coefficients in the two equations reasonably close; their 
SD values are almost the same. This proves that inclusion of the additional descriptors (J+ and J-) 
in LFER makes sense for ionic species. A plot of experimental values of log Kp versus calculated 
values of log Kp on this equation is given in Publication 2. The data points for the anions and cat-
ions scatter randomly over the line of unit slope. That is, ionic species fit the equation very well.    
       The predictive standard deviation (PSD) derived from the leave-one-out statistics, is a useful 
estimate of the predictive power of the regression models, especially for our case that comprises 
the data for ionic species (Cruciani et al., 1992; Hawkins, 2004). The PSD value for our equation 
is 0.502, which is possibly close to what can be achieved without overfitting. This may be suffi-
cient for many purposes. Abraham and Martins (2004) pointed out that it is difficult to predict 
log Kp to less than around 0.5 log unit for large and varied data sets. This is understandable if the 




log Kp for passive permeation of the sodium ion and the tetraethylammonium ion across human 
skin were predicted using our equation. The predicted values are in fair agreement with the ex-
perimental values. This is the first time that permeation of an ion across a membrane has been 
predicted just from the physicochemical properties of the ion and membrane. This equation can 
also be applied to estimate log Kp values for partly ionized solutes based on the respective con-
tributions of neutral and ionic species.  
4.2.2 Effects of Ionization on the Overall Permeation and the Separate Partition and Diffusion 
As shown in Eq. 1.2, if we had data on partitioning into skin by anions and cations, we could dis-
sect ionic effects on permeation into partition and diffusion. In the absence of actual log Ksc data, 
we can use partition into cerasome as an estimate for partition into skin and then deduce an equa-
tion for log Dsc of ionic species, by subtraction of coefficients in known equations for skin per-
meation and partition into cerasome. From these above equations, we can then obtain the effects 
of ionization, by comparison with neutral solutes, on the overall permeation and the separate par-
tition and diffusion processes. The results show that neutral acids and bases permeate across hu-
man skin very much faster than the corresponding ionized species, but the actual Kp ratio de-
pends on their structures. Moreover, the poor permeability of anions is partly due to poor parti-
tion into the SC but mostly due to slow diffusion of the ionized species (by comparison to the 
neutral species). For cations, poor permeability is entirely due to very slow diffusion (again by 
comparison to the neutral species). All of the details are given in Publication 2. 
       As for ionic slow diffusion, a possible explanation is as follows: The ionized form definitely 
binds closer to the lipid bilayer interface in the SC than the neutral form. The solute moves in the 
lipid bilayers with preference towards lateral diffusion regardless of the solute size and location. 




(Mitragotri, 2003; Mitragotri et al., 1999). As a result, the ionic species encounters a larger re-
tarding effect to their movement. 
       Further, we suggest that diffusion of the base cations is made more difficult by the presence 
of negatively charged head-groups in the SC. As one of the major lipids in the SC, the only ion-
izable fatty acids impart a net negative charge to the intercellular lipid bilayers (Michniak-Koln 
et al., 2005). When the cations diffuse in the lipid layers, their movement will be retarded under 
the electrostatic attraction of negatively charged head-groups in lipids. 
4.3 Application of the Potts-Guy Model 
Potts and Guy (1992) proposed a QSPR model for log Kp based on partition parameters between 
water and model vehicles for the SC and molecular volume (see Eq. 1.1). As we introduced, this 
equation was deduced from Eq. 1.2. It is known that organic solvent-water partitions are not very 
good models for the skin-water partition. We can now use the partition into cerasome (as log k7.4 
in Publication 1) as a model to investigate the application of Eq. 1.1 on predicting log Kp of both 
neutral and ionic species. Here, the McGowan approximation for molecular volume (that is, V) is 
adopted. A MLR analysis of log Kp against log k7.4 and V for neutral and ionized compounds that 
are present both in our data sets for log Kp and log k7.4 (see Publication 2 and Publication 1), 
leading to Eq. 4.1. N is here the number of compounds or data points.  
    log Kp (cm s-1) = ‒ 4.437 + 0.164 log k7.4 – 0.759 V      (4.1) 
R2 = 0.293, SD = 1.079, N = 41 
It is obvious that only log k7.4 and V cannot explain the nature of skin permeation very well. But, 
this is not surprising. In the Potts-Guy model, log Dsc was suggested to be linearly, inversely re-
lated to molecular volume. Such a relationship may be very useful for estimation of log Kp val-




only. However, it is purely empirical in nature and gives little information as to the actual struc-
tural features of solutes that influence diffusion in the SC.  
   log Kp (cm s-1) = ‒ 2.221 + 1.488 log k7.4 – 0.852V     (4.2) 
R2 = 0.826, SD = 0.561, N = 22   
       Our previous discussion indicated that the effect of ionization on diffusion through the SC is 
striking for ionizable compounds. This is markedly different from diffusion in water, where ionic 
species diffuse at about the same rate as the corresponding neutral compounds (Hills et al., 2011). 
As a result, the empirical relationship between log Dsc and molecular volume breaks down for 
ionic species. We can now conclude that, the Potts-Guy model cannot be used to predict log Kp 
for ionic species. 
4.4 Contribution of this Study  
On the whole, this study has successfully achieved the initial aims, and mainly contributes to the 
progress of science in several aspects below: 
1) It was demonstrated that liposomes are chemically far apart from organic solvents as for 
interaction with solutes, and thus that organic solvents cannot be used as a general model 
for liposomes. 
2) It was confirmed that liposomes can model the SC on partition properties very well, and 
that the use of the proper lipid composition is rather significant for its chemical similarity 
with the SC. In addition, the commercially available cerasome can be considered as a rea-
sonable model. 
3) A LFER equation for skin permeation for both neutral and ionic species was constructed, 
which can be used to predict log Kp and characterize skin permeation. It is the first model 




4) It was found that neutral acids and bases permeate through human skin much faster than 
their corresponding ionized forms, but that the ratio of neutral to ionic permeation is de-
pendent upon the actual structure. And the poor permeation of ionic species is mainly due 
to their slow diffusion across the SC, especially for base cations.  
5) It was indicated that the Potts-Guy model based on partition parameters in model vehicles 
(even in liposomes) for the SC and molecular volume does not work for estimation of log 





The skin forms an extremely efficient barrier between internal organs and the external environ-
ment, but also provides an attractive administration route. Skin permeability (as log Kp) is a criti-
cal parameter for estimating transdermal delivery of chemicals in contact with the skin in phar-
maceutics and cosmetics. Given the fact that measurement of log Kp is quite time-consuming and 
laborious, various mathematical models based on understanding of the fundamental mechanisms 
underlying skin permeation have been proposed to estimate the otherwise unavailable log Kp. 
However, there has been no model up to now for prediction of log Kp of ionic species. In order to 
solve this problem, we proposed and investigated two potential solutions in this study: one is the 
Potts-Guy model on the basis of partition parameters in liposome-water systems and molecular 
volume (MV), and the other is the extended linear free-energy relationship (LFER), which can be 
used to predict biological membrane permeability of ionic species.  
        In this study, the compounds with a broad structural diversity were selected and their reten-
tion factors were measured in liposome electrokinetic chromatography (LEKC), where cera-
somes composed mainly of the stratum corneum (SC) lipids and liposomes (POPC80/PS20) were 
used as the pseudo-stationary phases, respectively. These two negatively charged membrane sys-
tems and a neutral immobilized artificial membrane (IAM) system from literature as a surrogate 
for neutral liposome-water partition were compared with various organic solvent-water partition-
ing systems using LFERs. It was observed that liposomes display a greatly different chemical 
environment from those of organic solvents, and no organic solvent can thus provide a general 
model for liposomes in partition processes. What is more, the correlation between the skin-water 
partition and organic solvent/liposome-water partitions was also investigated. The results show 




liposomes and all organic solvents. Further, the cerasome-water partition correlates better to skin 
permeation than other liposome-water partitions and microsomal binding. This is probably due to 
the unique structures of ceramides that occur in SC and consequently in cerasomes.  
        The log Kp values of nine acid anions and nine base cations were measured in this study. 
The data were used to construct a LFER equation for skin permeation of neutral species and ion-
ic species, together with experimental log Kp for both species in literature. The resulting equa-
tion, with a R2 value of 0.861 and a SD value of 0.462 log units, can be used to predict log Kp for 
neutral species and ionic species, as well as partly ionized solutes. The predicted values for the 
passive permeation of the sodium ion and the tetraethylammonium ion are in good accord with 
the experimental values. It was found that neutral acids and bases are much more permeable than 
their ionized forms, and that the ratio depends on the actual structure. Using the cerasome-water 
partition as a substitute for the skin-water partition, the effect of ionization of solutes on skin 
permeation was separated to those on partition and diffusion processes. The poor permeability of 
ionic species is largely due to slow diffusion through the SC, especially for base cations. 
        In addition, the Potts-Guy model based on the retention factors obtained in cerasome elec-
trokinetic chromatography (EKC) and MV was discussed. It was found that such a model cannot 
be applied to predict log Kp for ionic species because MV fails to account for their diffusion 
through the SC, even empirically. 
        In conclusion, LFER is a very useful tool for predicting skin permeation, not only for neu-
tral species but also for ionic species, whereas the Potts-Guy model may be useful for neutral 





Die Haut bildet eine äußerst effiziente Barriere zwischen dem Körperinneren  und der äußeren 
Umwelt und stellt aber auch einen attraktiven Applikationsweg dar. Die Hautpermeabilität 
(dargestellt als log Kp) ist dabei auf dem Gebiet der Pharmazie und Kosmetik ein entscheidender 
Parameter, um das transdermale Hautpenetrations- bzw. Hautpermeationsverhalten eines Stoffes 
nach dermaler Applikation abzuschätzen. Direkte Messungen des log Kp sind zeitaufwendig und 
mühsam. In der vorliegenden Arbeit wurden verschiedene, auf dem Verständnis grundlegender 
Mechanismen der Hautpermeation basierende, mathematische Modelle vorgeschlagen, um nicht 
verfügbare log Kp-Werte zu generieren. Bisher gab es jedoch kein Modell, um den log Kp von 
ionisierten Molekülen vorherzusagen. Um dieses Problem zu lösen, haben wir in dieser Arbeit 
zwei Lösungsmöglichkeiten für die Vorhersage von log Kp-Werten geladener Substanzen 
vorgeschlagen und im Weiteren diskutiert: Zum einen das Potts-Guy-Modell auf der Basis von 
Verteilungsparametern in Liposom/Wasser-Systemen und dem Molekülvolumen (MV), zum 
anderen die erweiterte lineare freie Energie-Beziehung (linear free energy relationship; LFER), 
die verwendet werden kann, um die Permeabilität geladener Stoffe durch biologische 
Membranen vorherzusagen. 
In dieser Arbeit wurden Verbindungen mit einer breiten strukturellen Vielfalt ausgewählt 
und ihre Retentionsfaktoren mit Hilfe von Liposom-Elektrokinetik-Chromatographie (liposome 
electrokinetic chromatography; LEKC) gemessen, wobei Cerasomen, hauptsächlich bestehend 
aus Lipiden des Stratum corneums (SC), bzw. Liposomen (POPC80/PS20) als pseudostationäre 
Phase dienten. Diese beiden negativ geladenen Membransysteme sowie ein System aus neutralen 
künstlichen immobilisierten Membranen (immobilized artificial membranes; IAM) 




Verteilungssystemen zwischen organischen Lösungsmitteln und Wasser unter Anwendung der 
LFER verglichen. Es wurde beobachtet, dass Liposomen eine sich von organischen 
Lösungsmitteln stark unterscheidende chemische Umgebung besitzen. Daher stellen organische 
Lösungsmittel kein allgemein gültiges Modell für Liposomen in Bezug auf Verteilungsprozesse 
dar. Der Zusammenhang zwischen der Haut/Wasser-Verteilung und der organischen 
Lösungsmittel/Liposom-Wasser-Verteilung wurde ebenfalls untersucht. Die Ergebnisse zeigen, 
dass Cerasomen im Vergleich zu herkömmlichen Liposomen aus Phospholipiden sowie allen 
organischen Lösungsmitteln eine höhere chemische Ähnlichkeit mit der Haut aufweisen. Darüber 
hinaus konnte für die Cerasomen/Wasser-Verteilung eine bessere Korrelation mit der 
Hautpermeation nachgewiesen werden, als für die Liposomen-Wasser-Verteilung oder die 
mikrosomale Bindung. Grund hierfür ist wahrscheinlich die einzigartige Struktur der Ceramide, 
die im Stratum corneum wie auch hier in den Cerasomen vorhanden ist. 
Die log Kp-Werte von neun sauren, anionischen Molekülen und neun basischen, 
kationischen Molekülen wurden in dieser Arbeit gemessen. Aus den generierten Daten wurde in 
Verbindung mit log Kp Werten aus der Literatur eine LFER-Gleichung für die Hautpermeation 
von neutralen und ionischen Molekülen entwickelt. Die resultierende Gleichung mit einem R2 
von 0,861 und einer Standardabweichung von 0,462 log Einheiten kann sowohl zur Vorhersage 
des log Kp-Wertes für neutrale und ionische Moleküle, als auch für Vorhersage des log Kp-Wertes 
teilweise ionisierter Substanzen verwendet werden. Die abgeschätzten Werte für die passive 
Permeation des Natrium-Ions und des Tetraethylammonium-Ions stimmen mit den 
experimentellen Werten gut überein. Es wurde erkannt, dass neutrale Säuren und Basen viel 
stärker permeieren als die dazugehörigen ionisierten Formen und dass das Verhältnis von der 
jeweiligen Struktur abhängt. Unter Verwendung der Cerasome/Wasser-Verteilung als Ersatz für 




Hautpermeation von den Effekten auf die Verteilung und Diffusionsprozesse getrennt. Die 
schlechte Permeation ionischer Moleküle beruht im Wesentlichen auf der langsamen Diffusion 
durch das SC, vor allem für basische Kationen. 
Darüber hinaus wurde das Potts-Guy Modell basierend auf den Retentionsfaktoren, welche 
mittels Cerasome Electrokinetic Chromatography (EKC) bestimmt wurden, und MV diskutiert. 
Es wurde herausgefunden, dass ein solches Modell nicht für die Schätzung von log Kp-Werten 
ionischer Moleküle angewendet werden kann, da MV daran scheitert, die Diffusion durch das SC 
zu erfassen - auch empirisch.  
Zusammenfassend lässt sich sagen, dass LFER ein nützliches Hilfsmittel ist, um die 
Hautpermeation nicht nur für neutrale, sondern auch für ionische Moleküle vorauszusagen, 
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A  Overall hydrogen bond acidity  
B Overall hydrogen bond basicity 
BBB Blood-brain barrier 
CE Capillary electrophoresis 
Cerasome EKC Cerasome electrokinetic chromatography 
Dsc Diffusion coefficient through stratum corneum 
E Excess molar refraction in (cm3mol-1)/10 
HPLC High-performance liquid chromatography  
hsc Diffusion path length in stratum corneum 
IAM Immobilized artificial membrane 
ILC Immobilized liposome chromatography 
k7.4 Retention factor obtained in cerasome electrokinetic chromatography 
Kp Skin permeability 
Ksc Partition coefficient in stratum corneum 
LEKC Liposome electrokinetic chromatography 
LFER Linear free-energy relationship 
MLR Multiple linear regression  
MV Molecular volume 
MW Molecular weight 
N Number of data points or compounds 




Plip Liposome-water partition coefficient 
Poct n-Octanol-water partition coefficient 
PC Phosphatidylcholine or Principal component 
PCA Principal component analysis  
POPC 3-sn-Phosphatidylcholine  
PS 3-sn-Phosphatidyl-L-serine  
PSD Predictive standard deviation 
QSPR Quantitative structure-permeability relationship 
R2 Squared correlation coefficient 
S  Solute dipolarity/polarizability 
SC Stratum corneum 
SD Standard deviation  
SP Equilibrium coefficient for a series of solutes in a given system 
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